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ABSTRACT 
 
Upon detection of a pathogen, plants initiate specific signaling events designed to prevent 
host colonization and pathogen proliferation. Appearance of the hypersensitive response 
(HR), a type of programmed cell death signifies activation of active defenses in response 
to a one-to-one recognition of host, Resistance or R gene, and pathogen, avirulence or avr 
gene, encoded products. Turnip crinkle virus (TCV), however, has been shown to 
suppress the ability of Col-0 Arabidopsis thaliana plants to produce the HR in response 
to an avirulence factor. The extent of suppression was quantified by measuring cellular 
electrolyte leakage resulting from programmed cell death. Interestingly, cellular ion 
leakage levels were significantly lower in TCV-infected plants when challenged with 
bacteria expressing either of two bacterial effectors avrRpt2 or avrRpm1, suggesting that 
TCV can suppress the HR to a range of HR-inducing avirulence factors. In order to 
determine the viral component(s) responsible for mediating this suppression, each of the 
five TCV open reading frames (ORFs) was tested using an Agrobacterium tumefaciens-
mediated transient expression assay in Nicotiana benthamiana. Though sequencing of the 
five TCV clones revealed mutations in the p28, p88, and p9 clones, Agro infiltration of 
an HR-inducing system in conjunction with individual TCV ORFs, or combinations of, 
was used to gather data to determine the role each may possess in the suppression 
phenotype. Full-length TCV was also expressed in the presence of AvrPto/Pto to 
establish suppression phenotype in Nicotiana. To assay for suppression of cell death in a 
heterologous system, both the mutant and wild-type clones were also tested in yeast for 
cell-death suppression induced by hydrogen peroxide exposure. 
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1 INTRODUCTION 
1.1 Plant-Pathogen Interactions 
Understanding the molecular basis of plant-pathogen interactions and how plants can be 
made more resistant to infectious and deleterious pathogens can be derived from an 
understanding of the plant’s inherent mode of disease resistance. Plants possess 
numerous mechanisms to cope with the harmful effects introduced by various biotic 
stressors. Upon pathogenic challenge, plants may typically invoke combinations of broad 
and specific defense responses to confine the pathogen to the entry site. These events 
may include increased levels of reactive oxygen species, upregulation of genes encoding 
cell-wall strengthening agents and anti-microbial phytoalexins, increased levels of 
benzoic and salicylic acid, and the mobilization of pathogenesis-related (PR) genes 
(Nimchuk et al., 2003). However, initiation of specific active defense responses requires 
molecular recognition between a host-encoded resistance gene (R gene) and a cognate 
pathogen-derived avirulence factor (avr gene) in a gene-for-gene specific manner (Flor, 
1971). In the absence of either gene product, the plant becomes susceptible to the 
pathogen and its subsequent infestation. Avirulence genes may also serve as virulence 
factors in the absence of a cognate R gene. Examples of this duality include avrRpt2 from 
Pseudomonas syringae pv. tomato, the causal agent of bacterial speck disease, which 
functions as an avirulence factor in resistant lines of Arabidopsis but as a virulence factor 
in susceptible lines (Chen et al., 2000). It is generally believed that pathogens first 
developed these genes to enhance their virulence on susceptible hosts, while plants 
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simultaneously evolved corresponding R genes as specific receptors to recognize and 
eliminate them (Lim and Kunkel, 2004). 
To understand the molecular basis of plant-pathogen interactions, we use the plant 
model Arabidopsis thaliana, Figure 1. While A. thaliana is not in itself a crop plant, it is 
a member of the Brassicaceae family and is related to agriculturally significant plants 
such as broccoli, cabbage, and radish. A. thaliana provides an ideal model for research in 
the area of molecular genetics due to its short six-week life cycle along with the added 
benefit of a fully-sequenced genome. Other advantages of using A. thaliana include 
copious seed generation, making it a valuable tool in transgenic studies, and its relatively 
small size. With 26,000 genes on five chromosomes characterized to date, the system 
provides an excellent genomic resource for studying plant biology. 
 
 
Figure 1:  Model Plant: Wild-Type Arabidopsis Thaliana - Ecotype Columbia-0 (Col-0) 
 
1.2 Molecular Recognition of Pathogens 
To date, many cognate plant-pathogen interactions have been identified and 
characterized. Pto, one of the first R-gene encoded proteins to be characterized, 
recognizes the Pseudomonas syringae avrPto and avrPtoB proteins to initiate resistance 
responses in tomato (Scofield et al., 1996; Martin et al., 1993). The Col-0 disease 
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resistance locus RPS2 mediates specific detection of the corresponding avirulence gene 
avrRPT2 (Kunkel et al., 1993). Likewise, the Cf-9 gene from tomato confers resistance to 
strains of the leaf mold fungus Cladosporium fulvum expressing the cognate Avr9 gene 
(Jones et al., 1994). The R-protein Rpm1 recognizes two Pst pv. tomato derived effectors 
AvrRpm1 and AvrB (Grant et al., 1995). Based on their sequences, R genes characterized 
to date fall into five main categories as shown in Table  (Martin et al., 2003).  
R genes falling into the classes I-III lack transmembrane segments and are thought to 
exert their activities from within the cytoplasmic space where they interact with 
avirulence factors employing the TTSS machinery for secretion into the cell. Bacterial 
effector proteins are typically secreted and injected through the plasma membrane into 
the host cell employing the Type III Secretion System (TTSS) (Hueck, 1998; Mudgett 
and Staskawicz, 1999). The TTSS machinery is encoded by the hrp (hypersensitive 
response and pathogenicity) locus and is required in many R-avr mediated interactions 
(Alfano and Collmer, 1996). 
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 Table I:  Classification of R genes involved in plant disease resistance (taken from 
Martin et al., 2003) 
Class Description Examples 
I Serine/threonine kinase catalytic activity; N-terminal myristylation motif 
Pto from tomato is the only 
member of this class 
II Contain LRR, NBS, N-terminal leucine zipper regions, and CC domains RPM1, RPS2, Pi-ta 
III 
Contain LRR, NBS, N-terminal leucine 
zipper regions, and TIR domains 
homologous to animal resistance genes 
TMV N gene, RPS4 
IV Extracellular LRR region; small cytoplasmic extensions 
All Cf genes from the tomato 
fungus Cladosporium fulvum 
V 
Extracellular LRR region with a 
cytoplasmic region possessing 
serine/threonine kinase activity 
Xa21 from Rice is the only 
member of this class 
 
Approximately 150 R genes in the A. thaliana genome have been identified. The majority 
of R genes characterized encode products belonging to the Class II family of proteins. 
The specificity of R protein function is largely thought to lie within the LRR regions, the 
most variable of the domains in these proteins. The NBS (nucleotide binding site) and 
LRR (Leucine Rich Repeat) share homology with nucleotide binding sequences and 
leucine-rich repeat motifs essential for protein-protein interactions, respectively while the 
CC (coiled-coil domain) consists of a repeated heptad sequence with interspersed 
hydrophobic residues (Dangl and Jones, 2001; Martin et al., 2003).  
Two popular mechanistic models to describe the interaction between plants and 
pathogens include the receptor-elicitor theory and the guard theory. The elicitor-receptor 
theory places the pathogen-secreted effector in the elicitor role, while the R gene product 
acts as its receptor as shown in Figure 2.  
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Figure 2:  The Receptor-Elicitor Theory 
 
To date however, only two direct R-avr interactions have been demonstrated.  The C-
terminal LRR region of the Pi- ta protein from rice specifically interacts with the rice 
blast fungus Magnaporthe grisea secreted AvrPita in yeast-two hybrid assays and in-
vitro binding assays. Moreover, loss of physical interaction in AvrPita mutants 
segregated with loss of Pi-ta mediated resistance in resistant rice lines (Jia et al., 2000). 
Likewise, the Pto protein in tomato both recognizes and physically interacts with avrPto 
and avrPtoB as determined using the yeast-two hybrid screening method (Kim et al., 
2002). The Pto-avrPto interaction is one the best characterized pathways in plant 
resistance. Pto possesses serine/threonine kinase activity to initiate immunity upon direct 
interaction with both avirulence factors and in fact is sufficient for triggering immunity in 
the absence of its cognate avirulence factor when overexpressed (Tang et al., 1999). Pto 
autophosphorylation is required for Pto and avrPto interactions. Moreover, mutations 
abolishing Pto kinase activity showed an inability to form an HR (Tang et al., 1999). 
However, direct physical interaction between Pto and its cognate avirulence factors is not 
sufficient to mediate immunity. Pto-mediated resistance requires the Prf gene and other 
associated factors for full immunity (Salmeron et al., 1996). Though physical interaction 
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between the Pto and avrPto comprises a key signaling event in the host immune response, 
it is not in itself sufficient to mediate the entire process. To date, other factors have been 
identified as downstream phosphorylation targets by Pto including the protein kinase Pti1 
and the Pti4, Pti5, and Pti6 family of transcription factors that play a role in the induction 
of pathogenesis-related genes (Zhou et al., 1995).  
Though the receptor-elicitor theory describes mechanisms for two well-characterized 
systems, there exists far more compelling evidence for indirect communication between 
R and avr proteins in the triggering of defense activation networks. Many R gene 
products have been postulated to function via the “guard” theory whereby modification 
of a different host factor by a foreign elicitor triggers active resistance as shown in Figure 
3. The R-protein serves as a surveillance mechanism to “guard” or monitor the status of 
the cellular targets. Once modification of the guarded protein occurs, the R protein 
initiates various defense responses to isolate and eliminate the pathogen.  
Recent data demonstrated that the presence of avrRpt2 caused elimination of a resistance-
related protein RIN4 even in the absence of RPS2 and this ability segregated with 
activation of the RPS2 pathway (Mackey et al., 2003, Axtell and Staskawicz, 2003). Rin4 
acts as the “guarded” component serving as a negative regulator for RPS2-mediated 
defense as shown in Figure 3. In 2003, Axtell and Staskawicz demonstrated that wild-
type Col-0 plants infiltrated with bacteria expressing mutant avrRpt2 alleles were unable 
to induce any elimination of RIN4 and that knock-down mutants of rin4 resulted in 
constitutive induction of active defense pathways in the absence of an avirulence factor. 
Interestingly, an unrelated avr, avrRpm1 also directly interacts with and modifies Rin4. 
AvrRpm1 causes hyperphosphorylation of Rin4. Further, Rin4 is required for Rpm1 
 6
mediated resistance (Mackey et al., 2002). Thus it appears that RIN4 may be a 
convergence point in the signal transduction of activated defense initiated by both 
avrRpm1 and avrRpt2. This would explain why transgenic Col-0 plants expressing 
avrRpt2 were unable to elicit the RPM1 mediated immune response when challenged 
with avrRpm1 (Chen et al., 2000; Ritter and Dangl, 1996).  
 
Figure 3:  The Guard Theory 
 
In further support of the guard theory, one set of researchers concluded, after extensive 
searching, that there was no evidence at all for any interactions between the Cf-9 protein 
and its cognate avirulence factor avr9 in elicitation of resistance, suggesting the existence 
of a factor that mediates interactions with both (Luderer et al., 2001). 
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1.3 Defense Responses and Pathogen Counter-defenses 
Evidence for pathogen-mediated suppression of host cell death has been demonstrated in 
both plant and animal systems. The Pseudomonas type III effector AvrPtoB was shown 
to inhibit host-induced cell death in the presence of the HR-inducing disease resistance 
gene pairs Pto/AvrPto and Cf-9/Avr9 (Abramovitch et al., 2003). Interestingly, AvrPtoB 
was also able to suppress PCD in yeast undergoing death-inducing treatment.  
The Psg pv. Phaseolociola (Pph) effector virPphA was able to suppress typical rapid HR 
induction, which ultimately lead to colonization of soybean by the bacteria (Jackson et 
al., 1999). The AvrPphF factor appeared to block HR induced by chromosomal avr 
effectors in Pph (Tsiamis et al, 2000). In mammalian cell lines, the TTSS effector YopJ 
from Yersinia pestis, the causal agent for bubonic plague disrupted phosphorylation-
based activation of host mitogen-activated protein kinase kinases (MAPKKs) leading to 
suppression of host immunity (Orth et al., 1999). A number of YopJ-like proteins in other 
species of Yersinia as well as other plant and bacterial systems display similar 
interference with host defense signaling pathways, modulating the immune response and 
eventually contributing to virulence (refer to Orth et al., 1999). In 2002, Hay and 
Kannourakis compiled a comprehensive review citing evidence for viral-mediated 
suppression of host-initiated cell death allowing for longer viral replication cycles and 
increased virulence. According to the review, a number of viruses opt to disturb 
apoptotic-related processes by variously interfering with cellular TNF and Fas signaling, 
caspases involved in initiation cell death, the IFN pathway and Bcl-2-related proteins, 
and cell cycle and oxidative stress regulation. Likewise, expression of the baculovirus 
anti-apoptotic p35 gene in tomato inhibits host induced programmed cell death by acting 
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as a strong caspase inhibitor and confers disease resistance to a broad spectrum of 
otherwise nectrotrophic pathogens (Lincoln et al., 2002; Zhou et al., 1998). Interestingly, 
there are no published examples of plant viruses suppressing PCD. 
Establishing the mechanisms of inhibition of programmed cell death in plant systems 
could lead to greater understanding of the same processes in animal viruses employing 
similar tactics. Similarities between host initiation of programmed cell death in plant and 
animal systems have been identified. In 2003, Liang et al. demonstrated shared elements 
in the regulation and execution of ceramide-mediated PCD in plants and animals. The 
formation of reactive oxygen species such as superoxides and hydrogen peroxide was 
shared by both plant and animal systems undergoing host-induced cell death (Jabs, T., 
1999). c-DNA obtained from A. thaliana was able to functionally complement a dad1 
(defender against apoptotic death 1) knock-out mutant cell line of hamster tsBN7 cells in 
preventing apoptosis, providing one of the earliest experimental justifications for 
functional apoptotic-related homologues across plant and vertebrate systems (Gallois et 
al., 1997). A more recent example was shown by Li and Dickman (2004) whereby 
transgenic tobacco plants expressing the human anti-apoptotic factor bcl-2 survived lethal 
treatments of severe heat and cold shock and chemical stress whereas wild-type tobacco 
plants did not. 
1.4 Turnip crinkle virus as a model 
Turnip crinkle virus, a member of the Carmovirus genus, is a small icosahedral, positive-
strand RNA virus with five ORFs (Carrington et al., 1989). The genome, as shown in 
Figure 4, encodes two replicase proteins, p28 and its readthrough product p88 required for 
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in-planta replication, two intercellular movement proteins p8 and p9, and one coat protein 
p38 required for encapsidation of the infectious virion (Hacker et al., 1992). 
 
 
Figure 4:  TCV Genome 
 
Upon TCV inoculation, the TCV-susceptible line Col-0 becomes systemically 
infected and develops the characteristic disease symptoms of vein striping, asymmetrical 
mid-vein formation, leaf chlorosis and discoloration as shown in Figure 5.  
 
a   b  
Figure 5:  Leaves from TCV-inoculated Col-0 plants at 10 dpi. Uninoculated, systemically infected 
leaf (a); inoculated leaves (b). 
 
Viral nucleic acids are transported through intercellular conduits called 
plasmodesmata that are formed during incomplete cytoplasmic dissociation when plant 
cells undergo cytokinesis (McLean et al., 1997). Though plasmodesmata are typically 
used for intercellular communication and for the transport of biomolecules, viruses 
commonly use them for cell-to-cell movement while employing the phloem for long 
distance movement (Carrington et al., 1996; Samuel G., 1934). Viral translocation 
typically originates from older, fully expanded “source” leaves to younger, developing 
“sink” leaves (Leisner et al., 1993)  
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A common feature displayed by viruses undergoing a double-stranded RNA 
intermediate is their ability to induce host-mediated RNA silencing as shown in Figure 6. 
This phenomenon has been observed and documented for a broad range of eukaryotic 
systems. Upon cytoplasmic replication of the virus, host detection of long double-
stranded RNA triggers a pathway that results in degradation of these molecules by 
ribonucleases into small 21-25 nt RNAs termed small interfering RNAs or siRNAs. 
These shorter oligonucleotides associate with what is known as the RNA Induced 
Silencing Complex, or RISC, to silence complementary strand mRNA transcribed from 
the viral genome in a sequence specific manner. Interestingly enough, many of these 
same viruses that induce RNA silencing also have mechanisms to silence them. The coat 
protein of TCV has been shown to possess suppression of RNA silencing capabilities (Qu 
et al., 2003).  
 
 
Figure 6:  Simplified schematic of RNA silencing 
 11
In Drosophila, the B2 protein from flock house virus is a potent inducer of host-
induced gene silencing while simultaneously suppressing it (Li et al., 2002). The 
potyvirus helper component proteinase HC-Pro is a strong suppressor of RNA silencing 
and prevents accumulation of the invading nucleic acids (Anandalakshmi et al., 1998; 
Vance and Vaucheret, 2001). Potato virus X also displays suppression of RNA silencing 
capabilities but to a much lesser extent than HC-Pro as the viral p25 protein was shown 
only to suppress the mobile silencing signals (Voinnet et al., 2000). 
1.5 TCV suppresses the HR 
Previous work (Hammond 2001) suggested that TCV was capable of reducing the host 
plant’s innate ability to induce the HR not only to itself but also to unrelated pathogens. 
Infiltrating with bacteria expressing avrRpt2 in systemically TCV-infected Col-0 plants 
produced a milder tissue collapse suggesting a reduced resistance response. Likewise, 
TCV-resistant Di-17 plants displayed attenuated HR on symptomatic leaves after TCV 
challenge in plants previously inoculated with TCV. This suppression was seen though 
both TCV RNA and the viral coat protein were detected in the suppressed tissue. As TCV 
coat protein serves as the avirulence determinant conferring resistance in Di-17 plants 
(Zhao et al., 2000), this suggested that the HR response was suppressed in these tissues. 
The same uninoculated symptomatic leaves also showed high levels of PR-1 induction. It 
was therefore concluded that the presence of TCV in systemically infected tissues 
correlated with suppression of HR induction. As this is the first documentation of a viral 
mediated suppression of cell death in plants, we sought to further extend previous 
findings that HR-lesions were visibly diminished in systemic TCV Col-0 plants.  
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1.6 Proposed Work 
In this thesis, we show quantitative evidence that the presence of TCV interferes with the 
induction of the HR in the presence of the avirulent factor avrRpt2. By measuring ion 
leakage from leaves challenged with bacteria expressing the avirulence factors in the 
absence and presence of TCV, we were able to quantify the extent of cell death at 
equivalent time points. Moreover, we were able to extend this observation to a 
completely different avirulence factor, avrRpm1. avrRpm1 possesses faster kinetics of 
PCD induction allowing detection of peak ion fluxes much sooner than leaves infiltrated 
with avrRpt2. 
In order to determine which viral component mediates this observed suppression, 
we isolated and cloned each of the five individual TCV open reading frames as well as 
the TCV genome into the Agrobacterium tumefaciens compatible pBTEX vector and 
transfected each construct into the Agro strain GV2260. Each of the TCV ORFs was 
cloned into the pBTex expression vector for use in the transient assay. Sequencing of the 
five TCV clones revealed mutations in the p28, p88, and p9 clones. The p28MUT 
contained a single amino acid change from tyrosine to cysteine due to an A → G 
mutation at position 59 in the sequence. The p88MUT sequence contained over five 
mutations while the p9MUT had two mutations resulting in significantly different 
residues in the amino acid sequence. As sequencing data was reviewed after performing 
transient assays with each construct, all experiments performed with both mutant and 
wild-type clones, are included. As future cloning efforts to reconstruct p28, p88 and p9 
could result in evidence for suppression, the data obtained from experiments with the 
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mutant proteins could be valuable in determining structure-function requirements. Both 
the p38 and p8 clones had full consensus with the TCV coding sequence. 
Each of the mutant and wild-type genes were expressed in Nicotiana benthamiana 
- a plant commonly used for transient transgene expression – in the presence of the PCD-
inducing combination of avrPto and Pto. Evidence and extent of suppression was 
determined by scoring leaves based on the percent of infiltrated area showing necrosis.  
To test for activity in a heterologous system, both the mutant and wild-type TCV 
ORFs were cloned into the yeast compatible vector p423 to test for anti-apoptotic activity 
in yeast treated with H2O2. Yeast strain INVSc1 was transformed with each of the TCV 
constructs and exposed to hydrogen peroxide treatment to induce oxidative stress. Yeast 
survival was determined by survival of colony forming units (cfus) upon plating.
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2 MATERIALS AND METHODS 
2.1 Plant Material and Growth Conditions 
Arabidopsis thaliana Col-0 plants were grown in Pro Mix BX soil (Premiere Horticulture 
Inc., Red Hill, PA) in Percival Scientific AR-60L growth chambers with a photoperiod of 
16 hours and a dark period of 8 hours. Growth chamber temperature was set to 23.0°C 
and 21.0°C during light and dark periods, respectively. Col-0 seeds were planted in flats 
and subsequently covered with plastic wrap to maintain high humidity conditions through 
germination and before the appearance of four true leaves. Plants were watered as needed 
by immersing the flats in 1-L of tap water. After the first two weeks of growth, water was 
supplemented with 0.35g/L Miracle-Gro®. Nicotiana benthamiana were grown in similar 
soil, humidity and light/dark conditions but at a constant temperature of 28°C. Upon 
germination in high humidity conditions, seedlings were transplanted to individual pots. 
Auxiliary meristem sections were removed from developing plants to encourage 
enhanced growth of leaf tissue area. Plants were watered as needed and supplemented 
with 0.35g/L Miracle-Gro® once every two weeks after the initial four weeks of growth.  
2.2 Polymerase Chain Reaction (PCR) 
 
PCR was performed to isolate each of the five TCV open reading frames (ORFs) using 
the pT1D1∆L (Heaton et al., 1989; Akgoz et al., 2001) clone as template.   
Table II lists the primer pairs used to amplify each of the individual ORFs. PCR reaction 
conditions were 1X RedTaq Polymerase Buffer (Sigma-Aldrich, St. Louis MO), 1 µM 
each forward and reverse primer, 2.5 mM dNTPs, 1 unit RedTaq Polymerase (Sigma-
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Aldrich, St. Louis MO), and 10 – 50 ng template DNA. All reactions were carried out in 
50 µL volumes. Amplification was performed using the following thermocycler (Perkin 
Elmer Cetus Gene Amp PCR System 9600) conditions: 
1. 95ºC for 5 minutes (Initial Denaturation) 
2. 95ºC for 2 minutes (Denaturation) 
3. 68ºC for 1 minutes (Annealing) 
4. 72ºC for 1 minutes (Elongation) 
5. Repeat Steps 2 – 5 for 35 cycles 
6. 72ºC for 10 minutes (Final Elongation) 
7. 4ºC Hold 
 
 
Table II:  Primers for the Amplification of Individual TCV Open Reading Frames 
Target Forward Primer Reverse Primer 
p28MUT 5'-ATGCCTCTTCTACACACACTCAAC-3' 5'-CTAGCGGACAAAAGAGATCGC-3' 
p88MUT 5'-ATGCCTCTTCTACACACACTCAAC-3' 5'-TTAGAGAGTTGTAGGGAATTCG-3' 
p8 5'-ATGGATCCTGAACGAATTCCC-3' 5’-GCACTAGTTTTCCAGTCTAATG-3’ 
p9MUT 5'-ATGAAGGTTCTGCTAGTCACGG-3' 5’-GCACTAGTTTTCCAGTCTAATG-3’ 
p38 5'-ATGGAAAATGATCCTAGAGTCCGG-3' 5’-GACCAGCCCTTCTTCTG-3’ 
 
As full-length p88 encodes both p28 and p88, the p88∆STOP was created to produce 
only p88. The megaprimer method was used to change the 814G→C for removal of the 
p28 leaky stop codon and to incorporate a silent mutation at 832G→C by introducing a 
Sac I restriction site to test for incorporation of the mutation. The following mutagenic 
pair of primers was used: 5’-
GTCCGCTACGGGTGCTTGCGGGAGCTCGTCGGGAGGGAGACTC-3’ and 5’-
CCCGACGAGCTCCCGCAAGCACCCGTAGCGGACAAAAGAGATCG-3.   
Two rounds of PCR were performed – one using the p88 forward primer and the reverse 
mutagenic primer and the other using the p88 reverse primer and the forward mutagenic 
primer – to generate the “megaprimers”. Thermocycler conditions were as previously 
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mentioned. One final round of PCR was used to create the mutant using the following 
reaction conditions: 1X RedTaq Polymerase Buffer (Sigma-Aldrich, St. Louis MO), 1 
µM p88 forward primer, 1 µM p88 reverse primer, 2.5 mM dNTPs, 1 unit RedTaq 
Polymerase (Sigma-Aldrich, St. Louis MO), 25 ng PCR product 1, and 25 ng PCR 
product 2. All reactions were carried out in a 50 uL volume. Thermocycler conditions 
were as listed before. 
2.3 Cloning 
All PCR products were cloned into the pCR 2.1 cloning vector (Invitrogen, Carlsbad 
CA) and screened for desired directionality using the universal SP6 promoter forward 
primer and the reverse primer of the ORF or through restriction digestion analysis when 
appropriate. For cloning the ORFs into the agro-compatible binary vector pBTEX, the 
pCR 2.1 construct was digested with XbaI and KpnI, to excise the desired fragment and 
ligated into compatible sites between the cauliflower mosaic virus (CaMV) 35S promoter 
and a downstream NOS terminator sequence. For cloning into the yeast-compatible 
vector p423, the pCR 2.1 construct was digested with SpeI and XhoI, to excise the 
desired fragment and ligated into compatible sites downstream of the GAL1 promoter. 
The yeast vector contains a histidine synthesis and ampicillin resistance marker for 
selection in yeast and E. coli, respectively. The resultant recombinant plasmids were 
propagated in E. coli Top 10 cells and isolated using standard plasmid isolation 
procedures. 
Each construct was sequenced by Macrogen, Inc. (Korea). Only two clones, p38 and p8, 
were verified as accurate. Results of each sequencing reaction are listed in Appendix B. 
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2.4 Preparation of Chemically Competent E. Coli 
Fresh DH5α cells were plated from glycerol stocks onto LB plates (see Table ) 
containing no antibiotics. Cells were grown overnight in 37°C. A single colony was used 
to inoculate 25 ml of LB liquid media (Table ) without antibiotics. Cells were grown 
overnight in a shaker at 37°C at 200 RPM. The next day, the culture was used to 
inoculate a fresh 500 ml volume of LB without antibiotics in a 1 L flask. Cells were 
agitated at 37°C until the A600 was about 0.6 (after approximately 2 hours). The cells 
were then centrifuged at 4,000 RPM at 4°C for five minutes. The pellet was resuspended 
in 200 ml of ice-cold 50 mM CaCl2 and placed on ice for 10 minutes followed by 
centrifugation at 4,000 RPM for five minutes at 4°C. The pellet was resuspended in 40 ml 
ice-cold 20% glycerol-50 mM CaCl2. Aliquots of 1ml each were distributed to sterile 
microcentrifuge tubes and flash frozen in liquid nitrogen. All cells were stored in –80°C. 
2.5 Transformation of E. Coli – Heat Shock 
Stocks of chemically competent cells were taken from –80°C and thawed on ice. DNA 
was added to a 100 ul aliquot of competent cells, gently mixed with the end of a pipette 
tip, and kept on ice for 30 minutes. The cells were then placed in a 37°C water bath for 3 
minutes for transformation. Immediately thereafter, 1 ml of LB (see Table ) was added to 
the cells. After incubation at 37°C on a rolling drum for one hour, the cells were then 
spun down and plated on media containing the appropriate antibiotic for selection of 
transformants. 
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2.6 Transformation of E. Coli – Electroporation 
Stocks of previously made electro competent cells were taken from –80°C and thawed on 
ice. Approximately 100 ng of DNA in water was added to a 20-ul aliquot of competent 
cells and gently mixed with the end of a pipette tip. The mixture was then pipetted into a 
sterile electroporation cuvette and placed into the chilled electroporation chamber. The 
Cell-Porator® (Life Technologies, Carlsbad CA) was set to the following conditions: 
voltage booster = 4 kΩ, capacitance = 330 µF, and DC volts = low. A pulse of 2 kV was 
delivered to the sample. The sample was left in the cuvette for ten minutes and then 
transferred to 1 ml of LB media (see Table ). The sample was placed in a rolling drum at 
37°C for one hour. The cells were then spun down and plated on media containing the 
appropriate antibiotic for selection of transformants. 
2.7 DNA Mini Preparation 
A single colony was used to inoculate a 5-ml volume of LB media (see Table ) 
containing the appropriate antibiotic in a loosely capped 15-ml tube. The tube was placed 
in a rolling drum in a 37°C incubator for 16-18 hours. Approximately 1.5 ml of the 
culture was placed in a microcentrifuge tube and centrifuged at 14,000 RPM in a 
benchtop centrifuge for 30 seconds. The supernatant was removed leaving the bacterial 
pellet as dry as possible. The pellet was resuspended in 100 ul of ice-cold GTE solution 
(50mM Glucose, 25 mM Tris-HCl - pH 8.0 and 10 mM EDTA - pH 8.0) by vigorous 
vortexing. To lyse the cells, 200 ul of a freshly prepared solution of 0.2 M NaOH and 1% 
SDS was added to the tube and the contents subsequently mixed by inverting the tube 
rapidly several times without any vortexing. To the lysed cells, 150 ul of ice-cold 5M 
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KoOAC (5 M KOAC and 3 M Glacial Acetic Acid) was added and gently vortexed in an 
inverted position for approximately 10 seconds. The tube was placed on ice for 5 minutes 
to facilitate precipitation of the detergents. After centrifugation for 5 minutes, the 
resulting supernatant was transferred to a new tube. Two volumes of 
phenol/chloroform/isoamyl alcohol (25:24:1) was added to the supernatant and vortexed 
and then centrifuged for two minutes. The supernatant was transferred to a new tube 
without disturbing the organic layer. Double-stranded plasmid DNA was precipitated by 
adding two volumes of ice-cold ethanol. The mixture was then vortexed and placed in  –
20°C for a minimum of one hour, after which the samples were centrifuged for 30 
minutes. The supernatant was removed and the pellet resuspended in 30 ul of ultra-
distilled sterile water. A 1-ul aliquot of RNAse enzyme was added to the nucleic acid 
solution and incubated for 37°C for 30 minutes to degrade RNA in the sample.  For 
simple DNA preparations purposes, agarose gel electrophoresis was performed to verify 
plasmid integrity and yield. For post-ligation screening of colonies, samples were 
analyzed using restriction digestion analysis using 2.5 ul of DNA in a 15 ul total reaction 
volume. 
2.8 DNA Maxi Preparation 
A single colony was used to inoculate 100 ml of LB media (see Table ) in a 500 ml 
Erlenmeyer flask. The culture was incubated in a 37°C shaker for 16-18 hours with 
vigorous shaking. Cells were poured into a large centrifuge tube and were spun down at 
3,500 RPM for 15 minutes using the Sorvall RC-5B centrifuge (Sorvall GSA rotor). After 
removal of the supernatant, cells were resuspended in 6 ml of GTE buffer (50mM 
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Glucose, 25 mM Tris-HCl - pH 8.0 and 10 mM EDTA - pH 8.0).  To lyse the cells, 12 ml 
of a freshly prepared solution of 0.2 M NaOH and 1% SDS was added and gently mixed. 
The cells were placed on ice for 5 minutes after which 8 ml of ice-cold KOAC  (pH 4.8) 
(5 M KOAC and 3 M Glacial Acetic Acid) was added to precipitate the detergent. The 
cells were then iced for 20 minutes and centrifuged at 3,500 RPM for 15 minutes. The 
supernatant was poured through a 3-ply layer of cheesecloth into a new centrifuge tube. 
To precipitate DNA, 14 ml of ice-cold isopropanol was added. Immediately thereafter, 
the sample was centrifuged at 10,000 RPM for five minutes. After careful removal of the 
supernatant, the resulting pellet was dissolved in 200 ul TE buffer and transferred to a 
microcentrifuge tube. To the tube, 10M NH4OAc was added to make a final 
concentration of 2M NH4OAc. The sample was placed on ice for 10 minutes and then 
spun down at 14,000 RPM in a benchtop centrifuge for 10 minutes. The supernatant was 
transferred to a fresh tube. After adding two volumes of ethanol, the sample was placed 
in –20°C for one hour to overnight to precipitate double-stranded DNA. The solution was 
then spun down in a microcentrifuge for 10 minutes with resuspension of the pellet in 
100 ul TE buffer. 1 ul of a 10 ug/ml solution of RNAse A was added to the DNA and 
incubated for 37°C for 30 minutes. After incubation, a 1/10 volume of 3M NaOAc pH 
5.2  and two volumes of ice-cold ethanol were added to precipitate DNA. The solution 
was placed in –20°C for 30 minutes after which 42.7 ul of 5M NaCl and 37 ul of 30% 
polyethylene glycol (PEG)/1.5 M NaCl was added. The sample was vortexed and placed 
on ice for 30 minutes, and then spun down for 10 minutes. The pellet was resuspended in 
100 ul of ultra-filtered water and 100 ul of 2x proteinase K (PK) buffer and placed in a 
37°C water bath for 30 minutes. To complete the DNA prep, one volume of 
 21
phenol/chloroform/isoamyl alcohol (25:24:1) was added to the solution, vigorously 
vortexed and then spun down for two minutes. The aqueous phase was then transferred to 
a new tube to which two volumes of ice-cold ethanol were added. The solution was 
placed in –20°C for a minimum of one hour. The sample was spun down for five minutes 
and the pellet resuspended in 100 ul of ultra-pure water. DNA was quantified at A260 
using a spectrophotometer and also checked for protein contamination at A280. Minimal 
protein contamination was ensured at a A260/A280 ratio of 1.8 – 2.0. 
2.9 In-vitro transcription 
TCV-B was transcribed from pT1d1∆l. 12 ug of plasmid was linearized with XbaI. Two 
volumes of phenol/chloroform/isoamyl alcohol (25:24:1) was added to the restriction 
digest, vortexed and centrifuged at 14,000 RPM for two minutes. The supernatant was 
transferred to a new tube where 1/10 volume of 3 M NaOAC was added with vigorous 
vortexing, followed by two volumes of ice-cold ethanol. The DNA was placed in –20°C 
for one hour to precipitate DNA. The DNA was then centrifuged at 14,000 RPM for 30 
minutes. The pellet was resuspended in 15 ul of DEPC-treated water. Transcription was 
executed using 50 units of T7 RNA Polymerase (N.E. Biolabs, Beverly MA), 100 units 
of RNasin Ribonuclease Inhibitor (Promega, Madison WI), and 1mM of each 
ribonucleotide in 100 uL of 1x transcription buffer (N.E. Biolabs, Beverly MA) at 37 C 
for 2.5 hours. Afterwards, 15 units of RQ1 RNAse-free DNAse (Promega, Madison WI) 
was added. The reaction was incubated at 37°C for 30 minutes. To retrieve the RNA, 
phenol/chloroform/isoamyl alcohol (25:24:1) extraction was performed followed by 
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ethanol precipitation. After recovery of the pellet, RNA was resuspended in 50 ul DEPC-
treated water and quantified using the spectrophotometer. 
2.10 Viral Inoculation of TCV 
Infectious BBM-TCV, consisting of total RNA extracted form TCV-infected turnip, was 
resuspended in 1X inoculation buffer (0.05M glycine, 0.03 M K2HPO4 and 1% celite) to 
a final inoculum concentration of 0.2 µg/µl. Inoculations were performed at 24-26 dpp on 
older, fully expanded leaves. A sterile glass stirring rod was briefly dipped into 1-µl 
aliquots of the viral suspension and rubbed onto the adaxial side of several oldest leaves 
while using a stiff platform for abaxial support to provide adequate inoculum penetration. 
Plants were left in the growth chamber for 10 days to allow progression of TCV.  
N. benthamiana plants were inoculated in a similar manner. However, instead of 
inoculating with BBM virus, the plant was inoculated with in-vitro transcribed RNA. 
2.11 Bacterial Infiltration 
Fresh plates of Pseudomonas syringae pv. glycinea were streaked from glycerol stocks. 
A single colony was used to inoculate a 5-ml culture of fresh NYG media (see Table III) 
supplemented with 50 µg/ml kanamycin and allowed to grow overnight at 28°C. A 200-
ul aliquot was used inoculated to a fresh sub-culture to an A600 of 0.5-0.9. Samples were 
centrifuged at 3,000 RPM (Sorvall GSA rotor) for 10 minutes at 4°C. The pellet was 
resuspended in 10 ml of 10mM MgSO4 and re-centrifuged. The pellet was finally 
resuspended in 10 mM MgSO4 and samples were diluted to an A600 of 0.2. Bacterial 
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samples were syringe- infiltrated into symptomatic leaves of TCV and mock-inoculated 
plants at 10 days post inoculation.  
2.12 Ion Leakage Assays 
Four-6mm diameter leaf punches were obtained from symptomatic leaves harvested 18 
hours post infiltration and 5 hours post infiltration for avrRPT2 and avrRPM1, 
respectively. Leaf discs were subsequently floated on 2 ml ultra-pure water with abaxial 
sides towards the solution. Samples were incubated at room temperature for 4 hours and 
measurements obtained with a Cole-Parmer® 19815-00 Basic Conductivity Meter 
recently calibrated with Traceable One-Shot Conductivity Calibration Standard 
(Control Company, Friendswood TX). 
2.13 Preparation of Electro-competent Agrobacterium 
GV2260 cells were plated and incubated at 30°C for two days. Several colonies were 
then used to inoculate a 5 ml volume of LB (see Table ) supplemented with 100 mg/l 
rifampicin and 50 mg/l kanamycin. The culture was left to grow overnight on a rolling 
drum at 30°C. The next day, a 200-400 ul aliquot of the culture was used to inoculate 500 
ml of LB supplemented with 50 mg/l rifampicin. The flask was placed in a 28-30°C 
shaker at approximately 400 RPM until an A600 of about 0.5 was attained (usually 16-18 
hours). To harvest the cells, the flask was chilled on ice for 30 minutes and then 
transferred to centrifuge bottles and centrifuged in the Sorvall RC-5B centrifuge (Sorvall 
GSA rotor) at 4,000 RPM for 15 minutes and 4°C. The supernatant was discarded and 
cells resuspended in 500 ml of 1 mM Hepes pH 7.4 and spun again at the same 
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conditions. The cells were the resuspended in 250 ml 1mM Hepes pH 7.4 and spun again 
at the same conditions. The cells were once again resuspended in 10 ml of 1 mM Hepes 
pH 7.4 and spun down one final time at the same conditions. The cells were resuspended 
in 2 ml of ice-cold 10% glycerol. The competent cells were distributed into 40 ul aliquots 
per microcentrifuge tube, placed in liquid nitrogen, and then stored in –80°C until 
needed. 
2.14 Agrobacterium Transformation 
Cells were thawed at room temperature and then immediately placed on ice. About 25 ul 
of the cells was transferred to a sterile microcentrifuge tube. Approximately 80 ng of 
DNA was added to the cells in a volume not exceeding 2 ul. The cells and DNA were 
gently mixed and then pipetted into a sterile electroporation cuvette. The Cell-Porator® 
(Life Technologies, Carlsbad CA) was set to the following conditions: voltage booster = 
4 kΩ, capacitance = 330 µF, and DC volts = low. The cuvette was placed into the chilled 
electroporation chamber and pulsed at 1.4 kV. 1 mL of LB (Table ) was immediately 
added to the cells. The cells were left to incubate at room temperature, with no agitation, 
for one hour. The cells were then plated on LB/kan/rif plates and incubated for 2-3 days 
in 30°C. After isolated colonies appeared, transformants were used to inoculate 5 ml 
cultures of LB/rif/kan. Cultures were grown overnight at 30°C to make glycerol stocks. 
Transformants were verified using colony screening via PCR and then grown overnight 
in 5 ml of LB supplemented with the appropriate antibiotic. Cultures were used to make 
20% glycerol stocks to be stored in -80°C. 
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2.15 Agrobacterium-Mediated Transient Expression Assay 
Agro strains were streaked onto LB plates (see Table ) containing 50 mg/l kanamycin and 
100 mg/l rifampicin and grown for two days in 30°C.  Plates were kept for no more than 
two weeks at a time. New plates were always streaked from glycerol stocks. To start the 
cultures, a 5 ml volume of LB supplemented with 100 mg/l rifampicin and 50 mg/l 
kanamycin was inoculated with a smear of colonies and grown overnight in a rolling 
drum at 28-30°C. The cultures were then placed in a 15 ml Falcon tube and spun down at 
4,000 RPM for five minutes in the Sorvall RC-5B centrifuge (Sorvall GSA rotor) and 
then resuspended in 5 mL of induction medium (400 ml water, 4.88g MES, 2.5 g glucose, 
and 0.12 g NaH2PO4 and 25 mL AB salts (20 g NH4Cl, 6g MgSO4-7H2O, 3g KCl, 0.2g 
CaCl2, and 0.05g FeSO4-7H2O); 500 ul of 200mM fresh acetosyringone in DMSO 
prepared JUST prior to use) and spun again.  The pellet was resuspended in 5 ml of 
induction media. The culture was used to inoculate a 50 ml volume of induction media, 
50 mg/l kanamycin (rifampicin is not required at this step), in a 250 ml flask and was 
then cultured overnight in the large shaker at 30°C by simply turning the shaker heater 
switch off. The next day, the cultures were spun down in 50 ml Falcon tubes at 4,000 
RPM for five minutes and resuspended in 40 ml of 10 mM MES + 200 uM fresh 
acetosyringone in DMSO. The cultures were spun down again at 4,000 RPM for five 
minutes and then resuspended in 30 ml of 10 mM MES + 200 uM acetosyringone. To 
find the absorbance of the culture, a 1:10 dilution was made and used to make a final cell 
suspension absorbance of 0.3 using 10 mM MES + 200 uM acetosyringone as the 
diluting agent. For cell death suppression assays, HR-inducing agents such as the Pto and 
avrPto combination were mixed at a 1:1 ratio, while the candidate or known suppressor 
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or empty vector was mixed at a final ratio of 1:1 to the R-avr volume. Cases requiring 
coinfiltrations of more than one TCV ORF were mixed at equal ratios. For example, 3ml 
of 0.3 OD agro containing p28MUT and 3 ml of 0.3 OD agro containing p88MUT would 
be added to 3 ml of 0.3 OD agro containing avrPto and 3 ml of 0.3 OD agro containing 
Pto for a final solution volume of 12 ml and a final OD of 0.3 
For the transient expression assay, middle-aged leaves about the width of a hand length 
were selected. Small circles about the size of a quarter were made followed by a needle 
poke to the center of each circle. A 1-ml syringe was used to pressure infiltrate the Agro 
into the hole so as to cover the tissue demarcated by the marker.  Several duplicates of 
samples were made at varying leaf positions as leaf position does tend to affect the 
transient assay. Plants were moved to 24 hour light and moderate temperature conditions 
and monitored daily for transient expression phenotypes. For RNA extraction, leaves 
were harvested 36 hpi. Leaves were scored 7 dpi for final analysis of cell death 
suppression or progression. 
2.16 RNA Isolation from Plant Tissue 
Leaves were harvested from plants, weighed, and flash frozen in liquid nitrogen and 
placed in –80°C until preparation. Concert Plant RNA Reagent (Invitrogen) was used for 
RNA isolation from Arabidopsis thaliana and Nicotiana benthamiana leaves. After 
isolation, RNA was resuspended in DEPC-water with A260 quantification of yield using 
the spectrophotometer. RNA samples were always stored at –80°C.  
DEPC water was prepared by adding 200 ul of DEPC to 100 ml water. After vigorous 
shaking, the solution was autoclaved. All solutions used in the RNA prep were made 
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from autoclaved DEPC water. Note: Only autoclaved DEPC water may be used to 
prepare buffers to prevent ethylation of titratable groups and loss of buffer conditions. 
2.17 RNA Gel Electrophoresis 
RNA samples were run on a 1.2% agarose denaturing gel. To prepare the gel, agarose 
was first melted in distilled water. After cooling the superheated mixture, 1X gel running 
buffer (0.2M MOPS, 50 mM NaOAc and 1 mM EDTA) and 2.2 M 37% formaldehyde 
were added to the agarose solution. The gel was poured and allowed to solidify. After 
solidification, the gel was placed into an electrophoresis chamber containing1X gel 
running buffer. Approximately 10 ug of RNA was used per lane. 15 ul of denaturation 
buffer (1V 10X gel running buffer, 1.75V 37% formaldehyde and 5V 99% formamide) 
was added per 5 ul of RNA. The solution was mixed well and incubated at 55°C for 30 
minutes. After denaturing the sample, 1/10V loading buffer (50% glycerol, 1mM EDTA 
and 0.4% bromophenol blue) was added to the solution. The samples were loaded onto 
the gel and run until the bromophenol blue marker migrated 90% of the full length of the 
gel.  
To visualize RNA integrity, the gel was placed in a 0.1% Ehidium Bromide/DEPC water 
solution and gently agitated for 10 minutes. The gel was then placed under UV light, with 
minimal exposure, using the UV transilluminator to check for intact ribosomal RNA 
bands. The gel was destained by gentle agitation in DEPC water for 10 minutes. 
Occasionally the gel was saved for no more than 24 hours before blotting. 
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2.18 Northern Blots 
After gel electrophoresis, the gel was rinsed with several washes of DEPC water. The gel 
was then allowed to soak in alkaline transfer buffer (0.01M NaOH and 3M NaCl) for 10 
minutes. While soaking the gel, the membrane was prepared for subsequent RNA 
transfer. A section of positively charged nylon membrane was cut to a size approximately 
1 mm larger than the gel in both dimensions. The membrane was then carefully placed 
onto a container of DEPC water. After the membrane was fully wetted, the membrane 
was pushed into the water and allowed to soak for five minutes.  
After retrieving the gel from the alkaline transfer buffer, the gel was moved to a clean 
surface where a sharp scalpel was used to cut away unused portions of agarose and to cut 
one corner of the gel as a positional marker.  A similar cut was made into the nylon 
membrane after soaking to mark orientation of the gel.  
To assemble the capillary transfer system, a 3 cm stack of lab grade folded-paper towels 
was constructed. Sections of paper towel were cut approximately one inch greater than 
the gel in both dimensions. On the side, five pieces of filter paper cut to the size of the 
gel were set to soak in alkaline transfer buffer. To construct the second layer, two pieces 
of the wetted filter paper were placed on top of the first layer. The nylon membrane was 
then added as the third layer. The trimmed gel was then placed on top of the membrane 
as the fourth layer taking care to align the cut corners of the membrane and gel. Four 0.5 
inch-strips of parafilm were cut and each placed underneath the four sides of the 
perimeter of the gel to make a seal between the gel and membrane. At this point, care was 
taken to ensure that no air bubbles resided between the membrane and the gel.  
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The top of the gel was then wetted with transfer buffer and the remaining three wetted 
sections of filter paper were added on top of the gel. Two long 2-in X 24-in strips of filter 
paper were wetted in transfer buffer and placed on top of the gel with either end of the 
strip immersed in transfer buffer (see Figure 7). A thin glass plate was placed on top of 
the strips to prevent evaporation of buffer. A 100-g weight was finally placed on top of 
the entire assembly. One hour was typically sufficient for transfer of RNA to the 
membrane. After one hour the system was dismantled and the membrane placed in 5X 
SSC (22g NaCl, 11g sodium citrate in 400 mL water, pH to 7.0, top to 500 ml) for five 
minutes with gentle agitation. 
 
 
 100g 
 Alkaline Transfer Buffer Alkaline Transfer Buffer 
 
Figure 7:  Capillary Transfer System 
 
After soaking in 5X SSC, the membrane was transferred to a piece of 3 mm filter paper to 
dry. Upon complete drying, the membrane was placed onto a new piece of filter paper 
and placed into the FB-UVXL-1000 UV crosslinker (Fisher Scientific, Hampton NH), to 
fix the sample to the membrane, and set to “Optimal Crosslink”. After irradiation, the 
membrane was placed into a box containing 3 ul of a 400 ug/ml ethidium bromide 
solution for staining. The membrane was gently agitated for five minutes and then 
visualized using the UV transilluminator with minimal UV exposure. After observation 
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of the ribosomal bands, the membrane was destained by immersion in DEPC water and 
gentle agitation for 20 minutes. The membrane was then allowed to dry on a piece of 3 
mm filter paper and was then wrapped in plastic wrap and stored in 4°C.  
 
2.19 Northern Hybridization 
To prepare a probe for hybridization, 25 ng of purified DNA fragment was placed in a 
microcentrifuge tube. To the DNA, 24 ul of sterile water was added. The DNA was then 
randomly primed following using the Prime-it II kit (Stratagene, La Jolla CA). The 
reaction was incubated at 37°C for 30 minutes. After incubation, 150 ul of water was 
added to the reaction and the probe was ready for spin column purification. NucAway 
Spin Columns (Ambion, Austin TX) were used to recover purified probe DNA. After 
spin column purification, the probe was pipetted to a fresh microcentrifuge tube. Two 
scintillation vials were partially filled with scintillation fluid. A 2 ul-aliquot of purified 
probe was added to one vial and both vials were placed into the scintillation counter for 
measurement of radioactivity. Typical acceptable counts for a functional probe were 
around 20,000 cpm/ul. Probes possessing counts less than 10,000 were typically deemed 
inefficient and were not used.  
In preparation for hybridization, 1% BSA was freshly added to 10 ml of hybridization 
solution (0.5 M NaPO4, 1 mM EDTA and 7% SDS). The solution was poured into a 
glass hybridization tube followed by the membrane, RNA side facing into the tube, 
ensuring that the membrane was fully covered by solution. The tube was placed into the 
micro hybridization chamber and rotated for two hours at 65°C. The purified probe was 
kept on ice behind a polycarbonate shield in the interim. 
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After pre-hybridization of the membrane, the tube was opened and the solution discarded. 
A fresh 10 ml volume of hybridization buffer was prepared as described above and added 
into the tube. The probe was then boiled for 5 minutes in a water bath and then pipetted 
into the tube. The amount of probe to add should yield a final concentration of 
approximately 1 x 106 cpm solution. The tube was placed into the hybridization chamber 
and left to rotate for 18 hours at 65°C. 
After hybridization, the membrane was retrieved from the tube and immersed into Wash 
Solution #1 (1X SSC and 0.1% SDS) for ten minutes, with gentle agitation, at room 
temperature. After Wash #1, the membrane was returned to the tube along with Wash 
Solution #2 (0.5 SSC and 0.1% SDS). The tube was placed back into the chamber and 
rotated at 60 C for ten minutes. The membrane was then left to dry on plastic wrap. A 
Geiger Counter was used after each wash step to ensure removal of unhybridized probe.  
The dried membrane was placed into a cassette and exposed to a panel from the BAS 
1000 (Fujix, Kyoto Japan) phosphorimager for two hours. The panel was then developed 
in the phosphorimager for image capture and analysis. 
2.20 RT-PCR 
Using RNA harvested from leaves agro-infiltrated with TCV ORFs, 1 uL 50 uM oligo 
dT, 2 ug total RNA and 1 uL10 mM dNTPs were added to a microcentrifuge tube and 
brought to 13 uL with RNAse-free water or DEPC water (for samples containing the 
agro-infiltrated full-length TCV construct, Spe I primer was used in lieu of oligo dT). 
The tube was then placed in 65° C for 5 minutes and then spun down and placed on ice. 
To the tube, 4 uL of 5X First Stand Buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 
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mM MgCl2], 1 uL 0.1 mM DTT, 1 uL RNASEOUT™ Ribonuclease Inhibitor 
(Invitrogen, Carlsbad CA) and 1 uL SuperScript™ II Reverse Transcriptase (Invitrogen, 
Carlsbad CA) was added. The tube was placed in a 50° C water bath for one hour and 
then spun down and placed on ice. The enzyme was deactivated by placing the tube in 
70° C for 15 minutes. For amplification of the resulting cDNA, standard PCR was 
performed using an internal primer pair and the RT reaction as template. Typically 1 uL 
of the RT reaction in a 50-uL total PCR reaction volume was sufficient for amplification. 
Analysis was performed using standard gel electrophoresis. 
2.21 Yeast Transformation 
Fresh INVSc1 (Invitrogen, Carlsbad CA) yeast strains were streaked onto YPD plates 
(see Table ) from glycerol stocks and allowed to grow for 2-3 days at 30°C.  A single 
colony was then used to inoculate 10 ml of YPD media in a 25-50 ml flask. The culture 
was grown overnight in a 30°C shaker at 400 RPM. The 10 ml culture was used to 
inoculate 25 ml of fresh YPD in a 100 ml flask. The flask was placed in a 30°C shaker 
for 1-2 hours until A600 as about 1. The culture was then transferred to a 50 ml falcon and 
spun down at 3,000 RPM in the Sorvall RC-5B (Sorvall GSA rotor) at 4°C for 5 minutes. 
The cells were then resuspended in 40 ml of ice-cold sterile water and spun at 2,500 
RPM at 4°C for 5 minutes. The wash was repeated with 20 ml sterile ice-cold water at 
2,500 RPM for 5 minutes. The pellet was resuspended in 5 ml ice-cold 1 M glycerol. The 
culture was then centrifuged a final time at 2,000 RPM at 4°C for five minutes. The cells 
were resuspended in 150 ul of ice-cold 1 M glycerol and transferred to a sterile 1.5 ml 
microcentrifuge tube and kept on ice until ready for transformation. A 20 ul aliquot of 
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yeast cells were transferred to a sterile microcentrifuge. Approximately 5 ug of DNA in 
distilled water was added to the cells in a volume no more than 5 ul. The mixture was 
carefully pipetted into a sterile electroporation cuvette and placed into the chilled Cell-
Porator® (Life Technologies, Carlsbad CA) chamber and set to the following conditions: 
voltage booster = 4 kO, capacitance = 330 µF, and DC volts = low. Cells were 
electroporated at 1.5 kV. Immediately thereafter, 1 ml of 1M ice-cold glycerol was added 
and the cells left to incubate at room temperature for one hour without agitation. The 
cells were then plated on SD plates and incubated at 30°C. 
2.22 Yeast Cell Death Assays 
Wild-type INVSc1 cells were transformed with the appropriate constructs just prior to 
performing each experiment. Transformants were then selected and grown in 10 mL SD 
media, lacking histidine (see Table I), and 2% glucose and grown overnight to select for 
the presence of the plasmid. The cells were then centrifuged at 3,500 RPM for five 
minutes and resuspended in SD medium, lacking histidine, containing 2% galactose and 
1% raffinose. The cells were centrifuged again at 3,500 RPM for five minutes and 
resuspended in 10 ml of SD/gal/raff/-his media to induce expression from the GAL1 
promoter in p423. 
The yeast cells were induced for six hours with agitation at 30°C. After six hours, cells 
were diluted to an A600 of 0.05 in a total volume of 10 ml of SD/gal/raff/-his and were 
stressed by either chemical treatment or heat shock treatment. For chemical treatment, 
cells were treated with 3 mM H2O2 final concentration in the medium and incubated at 
30°C with vigorous shaking at 800 RPM for 6 hours. For heat stress, yeast cells were 
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incubated at 37°C for 30 minutes with vigorous shaking at 800 RPM, then transferred to 
a stationary water bath at 50°C for 30 minutes, and then returned to 30°C with vigorous 
shaking at 800 RPM for 6 hours. Following treatments, cell viability was determined by 
plating five serial ten-fold dilutions, using SD-/gluc media as the diluting agent, of each 
sample on SD/-his plates. To ensure cell viability, both wild-type and transformed cells 
were grown at 30°C for six hours with agitation at 400 RPM. Wild-type yeast cells were 
also subject to heat treatment and chemical treatment to ensure cell susceptibly to 
stressful conditions. 
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Table III:  Media Recipes - Based on 1L total volume 
Media Liquid Solid 
LB 
10.0 g tryptone 
10.0 g sodium chloride 
5.0 g yeast extract 
10.0 g tryptone 
10.0 g sodium chloride 
5.0 g yeast extract 
20.0 g agar 
NYG 
5.0 g Bacto Proteose 
Peptone #3 (BD, Sparks MD) 
3.0 g yeast extract 
80.0 mL 25% glycerol 
5.0 g Bacto Proteose 
Peptone #3 (BD, Sparks 
MD) 
3.0 g yeast extract 
80.0 mL 25% glycerol 
15.0 g agar 
YPD 
10.0 g yeast extract 
20.0 g Bacto Proteose 
Peptone #3 (BD, Sparks MD) 
20.0 g dextrose 
10.0 g yeast extract 
20.0 g Bacto Proteose 
Peptone #3 (BD, Sparks 
MD) 
20.0 g dextrose 
20.0 g agar 
SD 
26.7 g Minimal SD Base 
(Clontech, Palo Alto CA) 
0.77 g -His DO Supplement 
(Clontech, Palo Alto CA) 
26.7 g Minimal SD Base 
(Clontech, Palo Alto CA) 
0.77 g -His DO 
Supplement (Clontech, 
Palo Alto CA) 
20.0g agar 
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3 RESULTS  
3.1 TCV suppresses formation of HR to avrRpt2 
Col-0 plants infiltrated with P. syringae strains expressing either endogenous or plasmid-
encoded avrRpt2 typically form visual HR lesions within 24 hours (Shapiro et al., 2001). 
In previous experiments, TCV-infected Col-0 plants showed a marked reduction in lesion 
size or severity. In order to quantify the apparent suppression of the HR, an ion leakage 
assay approach was used, as electrolyte leakage is a common hallmark of PCD (Rate and 
Greenberg, 2001).  
Before commencing experiments investigating TCV-mediated suppression of avrRpt2 
induced PCD, it was necessary to establish the time of peak ion flux in avrRpt2-induced 
PCD in the absence of TCV. Accordingly, Col-0 plants were infiltrated with Psg carrying 
the avrRpt2-expressing vector. Leaf punches were harvested at 14, 16, 18 and 20 hpi. 
Maximum conductivity for each of the three samples was apparent at 18 hours post 
infilatration, as shown in Table IV. Leaves from all subsequent ion leakage assays 
involving avrRpt2 mediated PCD were scored at 18 hpi consistent with the time-trace 
experiment detailed in Table IV. 
In order to assay the effect of TCV on ion leakage, three-week old Col-0 plants were 
inoculated with TCV. Upon appearance of viral symptoms, the uninoculated but 
symptomatic leaves were challenged with one of the following: buffer, Psg carrying an 
empty vector, or Psg carrying a vector encoding avrRpt2. Equivalent size and age leaves 
were infiltrated on all mock-TCV inoculated plants. Samples representing negative 
controls were mock-bacterial and mock-viral inoculated with 10 mM MgSO4 infiltration 
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buffer and inoculation buffer, respectively. After bacterial infiltration, leaf punches were 
taken from infiltrated tissue and analyzed for conductivity. 
 
Table IV: Time course data for determination of peak ion flux upon avrRpt2-
induced PCD. Three-week old Col-0 plants were either mock-infiltrated with 10 
mM MgSO4, bacterially-infiltrated with Psg harboring an empty vector, or 
bacterially-infiltrated with Psg carrying a plasmid expressing avrRpt2. All 
infiltrations were done with 107 cfu/mL.  Four 6-mm leaf punches were taken at the 
indicated time points and assayed for conductivity. 
Time (hpi) Mock Infiltrated Psg (Empty) Psg (avrRpt2) 
14 42.6 43.3 85.2 73.9 74.4 32.7 
16 49.3 46.6 32.2 38.5 89.5 108.5 
18 44.5 47.2 43 48.6 140.7 101.2 
20 43.7 33.7 28.5 32.1 156.3 30.2 
 
 
 
Figure 8 shows the results of three independent trials. Untreated leaves show a 
low level of ion leakage due to the mechanical damage to cells at the cut site. Mock 
bacterial infiltration with bacteria carrying an empty vector show a level of ion leakage 
not significantly different than the untreated leaves. This is true for both the TCV 
infected plants and the plants not inoculated with virus. A large increase in conductivity 
was seen in the leaves infiltrated with the avr and that were not infected with TCV. This 
large increase is characteristic of tissue undergoing programmed cell death. In contrast, 
TCV-infected leaves leaf samples challenged with avrRpt2 showed a significant decrease 
in conductivity providing evidence of inhibition of cell death in leaves harboring the 
virus.  
Averaging the data from the three independent experimental trials, the conductivity for 
HR suppressed samples was consistently half that of its virus free counterpart as shown 
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in Figure 9. In fact, after subtracting the background seen in untreated tissue, the TCV-
infected tissue showed a four-fold decrease conductivity. 
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Figure 8: Quantification of AvrRpt2-induced Programmed Cell Death by Ion 
Leakage. Three week-old Col-0 plants were inoculated with 0.2 ug/uL TCV. After 10 
days, plants were either mock-infiltrated or Psg infiltrated with 10mM MgSO4 or 107 
cfu/ml, respectively. Four 6-mm leaf discs were taken 18 hours post infiltration and 
analyzed for conductivity. Plot shows conductivity values obtained from three 
independent trials. Each trial consisted of three samples of four leaf discs each. Blue 
and yellow bars show ion leakage data for leaves infiltrated 10 days post-viral 
inoculation, while red bars shows data for leaves infiltrated 13 days post-viral 
inoculation. 
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Figure 9:  Statistical Analysis of avrRpt2-induced PCD Quantification in Col-0. 
Bars represent the average of three independent trials consisting of nine total 
samples. Letters above bars represent distinct significance groups as determined by 
the Tukey-Kramer Method for multiple sample comparisons.  Each group differs 
from the others at a confidence level of P = 0.05. All statistics were performed using 
NCSS statistical software. 
3.2 TCV suppresses formation of HR to avrRpm1 
In order to determine if TCV could suppress the HR to a different avr, a similar set of 
experiments were carried out - the only difference being the avr carried on the plasmid in 
these experiments was avrRpm1. To establish HR suppression, Col-0 plants were either 
mock inoculated or inoculated with TCV. Ten days post viral inoculation, the 
symptomatic leaves and equivalent sized leaves on mock-inoculated plants, were 
infiltrated with one of three samples: 10 mM MgSO4, Psg carrying an empty vector, or 
Psg carrying a vector encoding avrRpm1. Since the kinetics of HR to avrRpm1 is much 
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quicker than avrRpt2, conductivity and tissue collapse was monitored at 5 hpi rather than 
18 hpi (Shapiro et al., 2001).  
As predicted, leaf samples subjected to P. syringae strains expressing avrRpm1 
displayed the highest levels of conductivity as shown in Figure 10. 
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Figure 10:  Quantification of AvrRpm1-induced Programmed Cell Death by 
Ion Leakage. Three week-old Col-0 plants were inoculated with 0.2 ug/uL 
TCV. At 10 dpi, plants were then either infiltrated with 10mM MgSO4 or 
infiltrated with or 107 cfu/ml of Psg. Four 6-mm leaf discs were taken 5 hours 
post infiltration and analyzed for conductivity. Plot shows conductivity values 
obtained from two independent trials. Each trial consisted of three samples of 
four leaf discs each (a). Pictures of Psg avr infiltrated leaves at 5 hpi from 
plants mock-inoculated (b) or virus infected (c). 
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In contrast, the leaves that harbored virus showed a much smaller increase in 
conductivity levels upon infiltration with Psg carrying the avr, and in fact, showed values 
similar to all the other groups. Averaging the data from the two independent experimental 
trials, the conductivity for HR suppressed samples was consistently 2.5 times less that of 
its virus free counterpart as shown in  
Figure 11. After subtracting the background seen in untreated tissue, the difference is 
four-fold. 
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Figure 11:  Statistical Analysis of avrRpm1-induced PCD Quantification in 
Col-0. Bars represent the average of two independent trials consisting of six 
total samples. Letters above bars represent unique significance groups as 
determined by the Tukey-Kramer Method for multiple sample comparisons. 
Each group differs from the others at a confidence level of P = 0.05. All 
statistics were performed using NCSS statistical software. 
3.3 Pto/AvrPto Challenge of TCV infected Nicotiana benthamiana  
With the eventual goal to determine the viral component responsible for reducing or 
suppressing the HR, we began developing a new system for monitoring the TCV 
suppression of HR. A transient assay in Nicotiana benthamiana was recently used to 
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demonstrate the ability of avrPtoB to suppress the HR (Abramovitch et al, 2003). In order 
to utilize this system effectively, it was first necessary to determine if TCV could 
suppress the HR in these plants. As it had previously been shown that TCV could 
systemically infect N. Benthamiana (Lin and Heaton, 1999), four-week old plants were 
inoculated with in vitro transcribed TCV genomic RNA. At 22 dpi, viral symptoms were 
clearly visible on younger leaves. Symptoms of infections included leaf wrinkling, 
stunted growth, rough texture and vein coloring causing a mottled appearance. 
 
 
a 
b 
c 
d 
 
Figure 12:  TCV infection in Nicotiana benthamiana at 22 dpi. Four 
week-old plants were either mock inoculated or TCV inoculated 
with 0.2 ug/uL RNA. Mock-Inoculated plants (a) and (b) TCV 
inoculated plants (c) and (d). 
 
Symptomatic and asymptomatic leaves of TCV-infected and control plants were then 
infiltrated with a mixture of Agrobacterium tumefaciens carrying two different plasmids. 
One encoded for avrPto while the other encoded for Pto. Under normal conditions, co-
expression of these two proteins results in a visible HR throughout the infiltrated area 
(Abramovitch et al., 2003)  
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 Three different types of leaf tissue were infiltrated – symptomatic young leaves 
and middle-aged leaves, and older, uninoculated leaves. Older leaves were included as a 
control since virus was not anticipated to be present in these tissues allowing, 
measurement of PCD activity in the absence of virus. Symptomatic young and middle-
aged leaves were infiltrated to assay for HR suppression as these leaves harbor active 
virus.  
These experiments were evaluated two different ways – electrolyte leakage 
measurements taken within two days following infiltration and visual inspection of the 
tissue after several days. For the ion leakage test, leaf punches were taken at 30 hpi and 
48 hpi. These time points were selected because older leaves were showing visible signs 
of tissue collapse.  
Figure 13 shows conductivity readings for the two time points.  
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Figure 13:  Quantification of AvrPto/Pto induced Programmed Cell Death in 
N. benthamiana plants. Four week-old plants were inoculated with 0.2 ug/uL in 
vitro transcribed TCV. Plants were then either mock-infiltrated or Agro 
infiltrated with 10mM MES or with bacteria at A600 = 0.3, respectively. Four 6-
mm leaf discs were taken analyzed for conductivity. Plot shows conductivity 
values obtained at 30 hours (blue bars) and 48 hours (red bars) post 
infiltration. 
 
As expected, older leaves revealed the highest conductivity levels in both TCV 
and control plants. In the virus free plant, the peak of conductivity is at 30 hpi and 
decreases considerably at 48 hpi. The TCV-infected older leaves show a different pattern 
with a higher level of ion leakage at 48 hpi but the difference is not so great between the 
time points. Interestingly, the younger and middle-aged leaves of the virus-free plant 
showed little ion leakage at either time point. However, by 4 dpi visual inspection 
showed significant tissue collapse. Isolating the time point at which peak ion flux occurs 
in these younger mock-inoculated tissues is crucial before extending the analyses to 
include TCV. Overall, the range of conductivity values in the TCV-infected plant was 
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higher and much broader indicating that the virus may variably affect the PCD pathway 
as visual inspection of younger and middle-aged TCV-infected leaves showed variable 
levels of lesion formation, from 5 – 100%, when scored 7 dpi. 
3.4 Transient Expression of TCV in Nicotiana Benthamiana 
The entire TCV-genome was cloned into the Agrobacterium compatible plant expression 
vector pBTex for use in the transient assay system. The clone was sequenced and 
checked. The p28, p9, and p38 ORFs had full consensus. The p88 ORF contains a single 
amino acid change from glutamic acid to glutamine. Moreover, p88 and p8 will need to 
be resequenced as their sequence data was incomplete. 
The full-length TCV clone was then tested to check for recapitulation of a viral 
infection. After infiltration of N. benthamiana plants with Agro carrying the vector, 
samples were harvested 2, 4, and 6 dpi from Agro-infiltrated leaves. To determine 
whether the expressed virus was spreading from infiltrated tissue to uninfiltrated tissue, 
sections of leaves proximal to infiltration sites were harvested at 4 and 6 dpi. RT-PCR 
was performed on RNA extracted from these samples to detect for presence of TCV. 
Figure 14 shows the results of the RT-PCR analysis.  
 
 
Figure 14:  RT-PCR of Total RNA extracted from tissue 
infiltrated with TCV carrying the full-length TCV expressing 
vector. 1-kB DNA Ladder (Lane 1); Infiltrated leaf 2 dpi (Lane 
2); Uninfiltrated and infiltrated leaf 4 dpi (Lanes 3 and 4); 
Uninfiltrated and infiltrated leaf 6 dpi (Lanes 5 and 6); negative 
PCR control (Lane 7). 
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 As indicated by the figure, TCV transcript was detectable at 2 dpi. Movement of 
TCV to uninfiltrated sections of tissue was detected at 4 and 6 dpi. Active replication of 
the virion in infiltrated tissue was also evident as intensity of amplified cDNA increased 
from 4 to 6 dpi. 
3.5 Detection of Individual TCV ORFs in N. Benthamiana 
Each construct was transfected into Agrobacterium and infiltrated into N. 
benthamiana leaves. To determine if the constructs were being properly transcribed in-
planta, RNA gel blot analysis and RT-PCR were performed on total RNA extracted from 
infiltrated tissue. As the p28MUT:pBTEX clone was the first construct made, a gel blot 
analysis was used to detect p28MUT transcript. Figure 15 shows detection of p28MUT 
transcript in infiltrated leaves. 
 
 
MUT 
a b
Figure 15:  RNA gel blot detection of p28MUT transcript in 
total RNA harvested from N. benthamiana leaves 36 hpi. 
Ethidium bromide stained RNA denaturing gel showing 50 ng 
pT1D1∆L DNA (Lane 1) and 10 ug total RNA from leaves 
infiltrated with agro carrying pBTEX expressing p28MUT 
(Lane 2) (a); RNA gel blot of the same gel blotted and 
hybridized with a p28 probe (Lane 2) (b). 
 
 To test for the presence of p8, p9MUT, p38 and p88MUT transcript, RT-PCR was 
used. Total RNA was extracted from N. benthamiana Agro-infiltrated with each of the 
 47
TCV ORFs. The RNA was then used as template for first strand synthesis by reverse 
transcription. The resulting cDNA was used as template for amplification using 
traditional PCR and primer pairs specific for each transcript as shown in Figure 16. 
 
 
ba 
Figure 16:  RT-PCR detection of TCV ORF transcripts in total RNA 
harvested from N. benthamiana leaves 36 hpi. 1-kB DNA Ladder 
(Lane 1) and amplified cDNA from leaves infiltrated with Agro 
carrying pBTEX expressing p88MUT (Lane 2) (a); 1-kB DNA Ladder 
(Lane 1), amplification of cDNA from leaves infiltrated with Agro 
carrying pBTEX expressing p8 (Lane 2), p9MUT (Lane 3) and p38 
(Lane 4) (b).  
3.6 Transient Expression of Individual TCV ORFs in N. benthamiana 
As previously discussed, N. benthamiana plants infiltrated with Agro expressing AvrPto 
and Pto display localized necrotic lesions – evidence of the HR and a functional R-avr 
interaction. Each of the TCV constructs was evaluated for anti-PCD activity in the 
presence of AvrPto/Pto-mediated PCD. Additionally, combinations of each of the 
constructs were also tested to see if the suppression phenotype required the presence of 
more than one component. For almost all of the systems tested, a variable extent of lesion 
formation was observed in the transient assay system, as shown in Figure 17-Figure 19. 
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       Leaf 1              Leaf 2            Leaf 3               Leaf 4                Leaf 5 
Figure 17:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with Agrobacterium carrying a vector 
expressing each of the TCV ORFs at an A600 = 0.3 in combination with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
Leaves were scored for suppression phenotypes 7 dpi. p28MUT(a) p88MUT(b) 
p8(c) p9MUT(d) p38(e) p28MUT,p88MUT(f) p28MUT,p8(g) p28MUT,p9MUT(h). 
Three different plants were tested. Leaves 1 and 2 were taken from one plant, while 
leaf 3 was taken from a second plant and leaves 4 and 5 were taken from a third 
plant. 
 
 The percentage of infiltrated area that resulted in tissue collapse varied from 5% 
to 100% in the five distinct samples expressing the same construct or combination of 
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constructs. The only combinations that showed consistency in observable phenotype was 
the p88MUT and p9MUT pair, panel (j) of Figure 18, and the p88MUT and p38 pair, 
panel (k) of Figure 18, which resulted in 90-100% tissue collapse in all five leaf samples. 
Tables B-1 through B3 in Appendix B show progression of necrosis from 4 dpi – 7 dpi. 
  
 Leaf 1                Leaf 2                  Leaf 3                 Leaf 4                 Leaf 5 
 
Figure 18:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with combinations of Agrobacterium carrying a 
vector expressing each of the TCV ORFs at an A600 = 0.3 with Agrobacterium carrying 
vectors expressing AvrPto and Pto, each at an A600 = 0.3. p88MUT, p8(i) p88MUT, 
p9MUT(j) p88MUT, p38(k) p28MUT, p38(l) p8MUT, p9MUT(m) p8, p38(n) p9MUT, 
p38(o). Three different plants were tested. Leaves 1 and 2 were taken from one plant, 
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while leaf 3 was taken from a second plant and leaves 4 and 5 were taken from a third 
plant. 
 
Minimal cell death was also observed for the p28MUT, p38 and p88MUT combination, 
panel (d) in Figure 19. Leaves scored at 7 dpi from this combination showed no more 
than a 10% total collapse of infiltrated tissue across both samples. However, samples 
containing these three components in addition to a fourth construct, showed a more 
variable percentage of collapse. The p28MUT, p38, p88MUT and p8 combination, as 
shown in Panel (k) showed almost 75–100% lesion formation in the infiltrated sites. 
However, the p28MUT, p38, p88MUT and p9MUT sample, Panel (l) showed reduced 
cell death phenotype with only 15-30% of the infiltrated area showing lesions. Table B-4 
in Appendix B shows progression of necrosis from 4 dpi – 7 dpi. 
 
 
Figure 19:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with combinations of Agrobacterium carrying a 
vector expressing each of the TCV ORFs at an A600 = 0.3 with Agrobacterium 
carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
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p8,p9MUT,p38(a) p28MUT,p88MUT,p8(b) p28MUT,p88MUT,p9MUT(c) 
p28MUT,p88MUT,p38 (d) p28MUT,p8,p38(e) p28MUT,p9MUT,p38(f) 
p88MUT,p8,p38(g) p88MUT,p9MUT,p38MUT(h) p88MUT,p8,p9MUT,p38(i) 
p28MUT,p8,p9MUT,p38MUT (j) p28MUT,p88MUT,p8,p38 (k) 
p28MUT,p88MUT,p9MUT,p38 (l) and p28MUT,p88MUT,p8,p9MUT (m). All 
samples were scored 7 dpi. All leaves were taken from the same plant. 
 
 Controls for the transient expression assays are shown in Figure 20-Figure 22 shows 
the results from ten separate co-infiltrations of Agrobacterium carrying the vector 
expressing avrPto and Pto on a single leaf from the same plant containing leaves 1 and 2 
in Figure 17 and Figure 18. At 7 dpi, only mild tissue collapse could be observed in each 
of the ten samples where full tissue collapse was expected. This is consistent with data 
from these same leaves infiltrated with TCV ORFs and displayed a much reduced 
severity of necrosis when compared with leaves from different plants. Plant to plant 
variation in induction of PCD-pathways may be accountable for this observation. 
 
 
Figure 20.:  Controls for Transient Expression Assays of TCV ORFs N. 
benthamiana. Eight-week old N. Benthamiana plants were infiltrated with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 
= 0.3. The leaf was scored 7 dpi for cell death phenotypes. All samples are 
from the same leaf. 
 
Figure 21 shows the results from twelve separate co-infiltrations of Agrobacterium 
carrying the vector expressing avrPto and Pto in combination with the anti-PCD effector 
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avrPtoB on a single leaf from the same plant containing leaves 4 and 5 from Figure 17-
Figure 18. As expected, leaf tissue was completely suppressed for cell death in each of 
the twelve samples at 7 dpi. 
Figure 22 shows each of the TCV ORF constructs along with avrPtoB, avrPto, and Pto 
constructs individually expressed in N. benthamiana plants. As expected, only tissue 
infiltrated with Agrobacterium carrying the vector expressing avrPto results in induction 
of an HR – consistent with previous findings (Abramovitch et al, 2003). 
 
 
Figure 21:  Controls for Transient Expression Assays of TCV ORFs N. 
benthamiana. Eight-week old N. Benthamiana plants were infiltrated with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 
0.3 in combination with Agrobacterium carrying the vector expressing 
avrPtoB at A600 = 0.3. The leaf was scored 7 dpi for cell death phenotypes. All 
samples are from the same leaf. 
 
 
Figure 22:  Controls for Transient Expression Assays of TCV ORFs N. 
benthamiana. Eight-week old N. Benthamiana plants were infiltrated with 
Agrobacterium carrying vectors expressing p8(a) p9MUT(b) p28MUT(c) 
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avrPtoB(d) avrPto(e) Pto(f) p38(g) and p88MUT(h) at A600 = 0.3. The leaf was 
scored 7 dpi for cell death phenotypes. All samples are from the same leaf. 
 
3.7 Expression of TCV ORFs in Sacharomyces cerevisiae 
To check for PCD suppression in a heterologous system, both the mutant and wild-type 
TCV ORFs were cloned into the yeast-compatible vector p423. The vector p423 contains 
a histidine selection marker along with a GAL1 galactose-inducible promoter. Prior to 
each yeast cell death assay, the constructs were transfected into competent INVSC1 yeast 
cells and selected using histidine-free media.  
Transformants were cultured overnight, induced and then subjected to stress by 
including 3 mM H2O2 in their growth media after induction. After the six-hour H2O2 
exposure, 20-uL aliquots of culture and each of 5 ten-fold serial dilutions of each of the 
samples were plated on His-free media to determine yeast survival. Untreated samples 
were also plated to compare viability with the treated cells.  
 Yeast transformed with p38 showed the greatest colony growth in dilution 3 of 
H2O2 treated cells when compared with the positive control avrPtoB. Likewise, yeast 
carrying the empty vector, along with the yeast samples carrying each of the TCV ORFs, 
showed a reduced extent of yeast survival for the same dilution. Untreated cells showed 
very similar concentrations as all constructs produced several colonies at the 5th dilution. 
However, the H2O2-treated cells showed a wide range of survival depending upon the 
construct it contained. Empty vector and vector encoding p28MUT and p88MUT showed 
10 or so cfu by the 3rd dilution. In contrast, avrPtoB and p38 had about ten times for cfus. 
 
 
 
 
 54
 
 
 
 
 
        AvrPtoB                     Empty                        p28MUT                     p38                         p88MUT 
 
 
 
a 
b
 
Figure 23:  Survival of S. cerevisiae strain INVSC1 expressing TCV ORFs 
undergoing oxidative stress. Untreated samples (a) and 3 mM H2O2 (b). 
Transformants were grown overnight and induced with galactose for six 
hours. Cells were then diluted to A600 = 0.05 and incubated for six hours at 
30°C in SD/-HIS or SD/-HIS supplemented with 3 mM H2O2. Samples were 
then plated along with five ten-fold dilutions to test for yeast survival. 
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4 DISCUSSION  
 
In this thesis, we have demonstrated that A. thaliana plants systemically infected with 
Turnip crinkle virus are suppressed in their ability to initiate a PCD-response when 
challenged with the cognate avirulence factor avrRpt2. Moreover, we were able to extend 
these findings to an entirely different avirulence factor, avrRpm1, which displays faster 
kinetics in the induction of the PCD pathway. Infiltration of TCV-infected leaves with 
either avr resulted in a significant four-fold difference in conductivity levels when 
compared with non-TCV infected leaves undergoing equivalent treatments. 
We propose that TCV may be involved in the modification of a host factor that is 
common between both the Rps2 and Rpm1 mediated PCD pathways as both Rps2 and 
Rpm1 initiate active defense in a Rin4 dependent manner. In fact, it has been shown that 
RPS2 knockout Col-0 plants overexpressing avrRpt2 were unable to mount an HR to 
avrRpm1 due most likely to avrRpt2-mediated elimination of Rin4 (Chen et al., 2000). 
The fact that Rps2 and Rpm1 both associate with Rin4 leads to the assertion that these 
two disease resistance proteins evolved out of necessity to monitor different pathogen-
induced modifications of Rin4 (Mackey et al., 2003). Interaction between plant virus 
proteins and host factors is not uncommon as the p8 movement protein was shown to 
directly interact with the Arabidopsis protein Atp8 in both yeast-two hybrid and in-vitro 
binding assays. As Atp8 was shown to possess two putative transmembrane fragments, 
TCV has the capability to exploit host factors to promote its own virulence (Lin and 
Heaton, 2001). 
We have also demonstrated that both the mutant and wild-type TCV constructs 
was transcribed in-planta. Moreover, full-length TCV expressed by agrobacterium was 
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not only expressed, but was able to reproduce endogenous viral movement as it was 
detected in uninfiltrated tissue.  
The results of the ion leakage assay in N. benthamiana plants challenged with 
avrPto and Pto were inconclusive. Though an increase in conductivity levels in older 
leaves was evident at 24 hpi with respect to untreated and mock tissue, peak ion flux for 
younger and middle-aged leaves was not determined. Before repeating the experiment 
with TCV infected plants, it is recommended that a time trace analysis be performed on 
healthy N. Benthamiana plants challenged with the AvrPto and Pto scheme to isolate the 
time point for maximum electrolyte leakage. The infiltrated leaves should be monitored 
for appearance of tissue collapse every twelve hours as lesions on these tissues were 
detectable by 4 dpi. Tracking of lesion formation using tables similar to those in 
Appendix B would reveal the time span in which these younger leaves invoke their PCD 
programs. Once that time point is established, leaves can be then be assayed for 
comparative assessment of ion leakage from both TCV and mock-TCV plants undergoing 
PCD. 
The p28-WT, p88-WT, and p9-WT clones will need to be reconstructed as soon 
as possible. If future experiments with these clones reveal HR suppression, data from the 
mutant constructs could provide some insight into key residues required for function. I 
wish the next person that constructs these clones the best of luck in showing that one of 
these ORFs plays a role in HR suppression. 
The ORFs from the full-length TCV were mostly fine except for a single glutamic 
acid to glutamine change in the p88 ORF. Moreover, p8 and p88 sequencing reactions 
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were incomplete, so it is recommended that these two ORFs be resent for sequencing to 
ensure full consensus. 
In the meantime, transient assays involving the p38 and p8 constructs will need to 
be repeated with more precise experimental parameters. As the plant-to-plant response in 
the HR severity under similar treatments was quite variable, there may be a concentration 
threshold for the agrobacterium to efficiently translocate T-DNA to the host genome. 
When testing three-way and four-way expression of TCV components, the overall 
concentration of the individual factors may need to be optimized to ensure sufficient 
delivery of each.  
Incorporating one of the R-avr schemes that we used for quantification of HR 
suppression may offer some new revelations in the use of the transient expression system. 
If TCV is operating through modification of a signaling component essential to both the 
RPS2 and RPM1 pathways, then we may not be able to observe any visible affect on HR 
induction in completely different systems such as avrPto-Pto and Avr9-Cf9. This seems 
to be a very promising alternative as we now have solid evidence that TCV interferes 
with both Rps2 and Rpm1 mediated immunity. 
 As Abramovitch et al. (2003) were able to show anti-apoptotic activity of avrPtoB 
in both plants and yeast, we tried expressing each of the TCV ORFs in yeast undergoing 
oxidative stress. Though we were only able to try the assay once, yeast expressing p38 
showed stronger survival rates with respect to avrPtoB. Performing the yeast apoptosis 
assay to duplicate the suppression phenotype of avrPtoB may help in optimizing the 
assay protocol for use with the TCV constructs. Inclusion of p8 and p9-WT will also 
need to be performed in future experiments. 
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APPENDIX A 
SEQUENCES OF TCV CLONES 
p28MUT Sequence 
ATGCCTCTTCTACACACACTCAACACAGCGCTCGCAGTGGGACTCCTAGGAGCCAGGTGCTACCCTGAGGTTCAAACCTTConsensus #1
10 20 30 40 50 60 70 80
ATGCCTCTTCTACACACACTCAACACAGCGCTCGCAGTGGGACTCCTAGGAGCCAGGTACTACCCTGAGGTTCAAACCTT TCVbGenome.txt
ATGCCTCTTCTACACACACTCAACACAGCGCTCGCAGTGGGACTCCTAGGAGCCAGGTGCTACCCTGAGGTTCAAACCTT SP6_Forward
ATGCCTCTTCTACACACACTCAACACAGCGCTCGCAGTGGGACTCCTAGGAGACAGGTGCTACCGTGAGGTTCAAACCTT T7Promoter_Reverse
CTTGGGGCTGCCTGACTACGTGGGTCACATGAAGAATGTAGTACGGTCTGTTTTCCAGGGATCTGGGCTAGTAGTAGTGTConsensus #1
90 100 110 120 130 140 150 160
CTTGGGGCTGCCTGACTACGTGGGTCACATGAAGAATGTAGTACGGTCTGTTTTCCAGGGATCTGGGCTAGTAGTAGTGT TCVbGenome.txt
CTTGGGGCTGCCTGACTACGTGGGTCACATGAAGAATGTAGTACGGTCTGTTTTCCAGGGATCTGGGCTAGTAGTAGTGT SP6_Forward
CTTGGGGCTGCCTGACTACGTGGGTCACATGAAGAATGTAGTACGGTCTGTTTTCCAGGGATCTGGGCTAGTAGTAGTGT T7Promoter_Reverse
CCTCCGACACAGTCGGTGTCAGGGGGACGTATAGTAATAGAGGTCAGATAGGTAGTAGTCTCGGGTGTATACTAGCCGTTConsensus #1
170 180 190 200 210 220 230 240
CCTCCGACACAGTCGGTGTCAGGGGGACGTATAGTAATAGAGGTCAGATAGGTAGTAGTCTCGGGTGTATACTAGCCGTT TCVbGenome.txt
CCTCCGACACAGTCGGTGTCAGGGGGACGTATAGTAATAGAGGTCAGATAGGTAGTAGTCTCGGGTGTATACTAGCCGTT SP6_Forward
CCTCCGACACAGTCGGTGTCAGGGGGACGTATAGTAATAGAGGTCAGATAGGTAGTAGTCTCGGGTGTATACTAGCCGTT T7Promoter_Reverse
CCGGATAGCGGGGCGGATATAGAAATAGACCTAGATAGGTTGGTAGGAACGGAAGAGGAAGCCACATCCTGTTTGGTGGAConsensus #1
250 260 270 280 290 300 310 320
CCGGATAGCGGGGCGGATATAGAAATAGACCTAGATAGGTTGGTAGGAACGGAAGAGGAAGCCACATCCTGTTTGGTGGA TCVbGenome.txt
CCGGATAGCGGGGCGGATATAGAAATAGACCTAGATAGGTTGGTAGGAACGGAAGAGGAAGCCACATCCTGTTTGGTGGA SP6_Forward
CCGGATAGCGGGGCGGATATAGAAATAGACCTAGATAGGTTGGTAGGAACGGAAGAGGAAGCCACATCCTGTTTGGTGGA T7Promoter_Reverse
GGCGGTAGGTAGTACCGCAGATGTCCCCAGGAGGAGAGTTCGTCAAAAGGGGCGGTTTGCTATGCATGCCGTCAACGCAGConsensus #1
330 340 350 360 370 380 390 400
GGCGGTAGGTAGTACCGCAGATGTCCCCAGGAGGAGAGTTCGTCAAAAGGGGCGGTTTGCTATGCATGCCGTCAACGCAG TCVbGenome.txt
GGCGGTAGGTAGTACCGCAGATGTCCCCAGGAGGAGAGTTCGTCAAAAGGGGCGGTTTGCTATGCATGCCGTCAATGCAG SP6_Forward
GGCGGTAGGTAGTACCGCAGATGTCCCCAGGAGGAGAGTTCGTCAAAAGGGGCGGTTTGCTATGCATGCCGTCAACGCAG T7Promoter_Reverse
CAAAGCTGCACTTTTGTGGCGTCCCAAAACCCACTGAAGCGAATCGACTAGCGGTCTCAAAATGGCTTGTCCAATACTGCConsensus #1
410 420 430 440 450 460 470 480
CAAAGCTGCACTTTTGTGGCGTCCCAAAACCCACTGAAGCGAATCGACTAGCGGTCTCAAAATGGCTTGTCCAATACTGC TCVbGenome.txt
CAAAGCTGCACTTTTGTGGCGTCCCAAAACCCACTGAAGCGAATCGACTAGCGGTCTCAAAATGGCTTGTCCAATACTGC SP6_Forward
CAAAGCTGCACTTTTGTGGCGTCCCAAAACCCACTGAAGCGAATCGACTAGCGGTCTCAAAATGGCTTGTCCAATACTGC T7Promoter_Reverse
AAAGAGAGACATGTCGTAGACAGCCACATCAGAACGATAGTCAATACGGCTCTTCCTAGAGTGTTCACGCCTGACGCGGAConsensus #1
490 500 510 520 530 540 550 560
AAAGAGAGACATGTCGTAGACAGCCACATCAGAACGATAGTCAATACGGCTCTTCCTAGAGTGTTCACGCCTGACGCGGA TCVbGenome.txt
AAAGAGAGACATGTCGTAGACAGCCACATCAGAACGATAGTCAATACGGCTCTTCCTAGAGTGTTCACGCCTGACGCGGA SP6_Forward
AAAGAGAGACATGTCGTAGACAGCCACATCAGAACGATAGTCAATACGGCTCTTCCTAGAGTGTTCACGCCTGACGCGGA T7Promoter_Reverse
AGACATTCAGGTCGTGCTGGATTTGCACAGTGTAAGAGCACACGACCACCGCAACGCCCTAGCCGAAGCAGGCAAAGTGCConsensus #1
570 580 590 600 610 620 630 640
AGACATTCAGGTCGTGCTGGATTTGCACAGTGTAAGAGCACACGACCACCGCAACGCCCTAGCCGAAGCAGGCAAAGTGC TCVbGenome.txt
AGACATTCAGGTCGTGCTGGATTTGCACAGTGTAAGAGCACACGACCACCGCAACGCTCTAGCCGAAGCAGGCAAAGTGC SP6_Forward
AGACATTCAGGTCGTGCTGGATTTGCACAGTGTAAGAGCACACGACCACCGCAACGCCCTAGCCGAAGCAGGCAAAGTGC T7Promoter_Reverse
GGAAGTGGTGGGTCAATCTCGCGATGCATCCCATGACTGGGAGGTCGTGGTCCAGGGCTTGGAGGCGATTATGCCGACTGConsensus #1
650 660 670 680 690 700 710 720
GGAAGTGGTGGGTCAATCTCGCGATGCATCCCATGACTGGGAGGTCGTGGTCCAGGGCTTGGAGGCGATTATGCCGACTG TCVbGenome.txt
GGAAGTGGTGGGTCAATCTCGCGATGCATCCCATGACTGGGAGGTCGTGCTCCAGGGCTTGTAGGCGATTATGCCGACTG SP6_Forward
GGAAGTGGTGGGTCAATCTCGCGATGCATCCCATGACTGGGAGGTCGTGGTCCAGGGCTTGGAGGCGATTATGCCGACTG T7Promoter_Reverse
CCTGACGACCAGGCGATCTCTTTTGTCCGCTAGConsensus #1
730 740 750
CCTGACGACCAGGCGATCTCTTTTGTCCGCTAG                                                TCVbGenome.txt
CCTGACGACCAGGCGATCTCTTTTGTCCGCTAG                                                SP6_Forward
CCTGACGACCAGGCGATCTCTTTTGTCCGCTAG                                               T7Promoter_Reverse  
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 p28MUT Translated 
 
MP L L HT L NT AL AVGL L GAR C YP E VQT F L GL P DYVGHMKNVVR S VF QGS GL VVVS S DT VGVR GT YS NR GQIConsensus #1
10 20 30 40 50 60 70
MP L L HT L NT AL AVGL L GAR YYP E VQT F L GL P DYVGHMKNVVR S VF QGS GL VVVS S DT VGVR GT YS NR GQI  TCVbGenome.txt
MP L L HT L NT AL AVGL L GAR C YP E VQT F L GL P DYVGHMKNVVR S VF QGS GL VVVS S DT VGVR GT YS NR GQI  SP6_Forward
MP L L HT L NT AL AVGL L GDR C YR E VQT F L GL P DYVGHMKNVVR S VF QGS GL VVVS S DT VGVR GT YS NR GQI  T7Promoter_Reverse
GS S L GC I L AVP DS GADI E I DL DR L VGT E E E AT S C L VE AVGS T ADVP R R R VR QKGR F AMHAVNAAKL HF C GConsensus #1
80 90 100 110 120 130 140
GS S L GC I L AVP DS GADI E I DL DR L VGT E E E AT S C L VE AVGS T ADVP R R R VR QKGR F AMHAVNAAKL HF C G TCVbGenome.txt
GS S L GC I L AVP DS GADI E I DL DR L VGT E E E AT S C L VE AVGS T ADVP R R R VR QKGR F AMHAVNAAKL HF C G SP6_Forward
GS S L GC I L AVP DS GADI E I DL DR L VGT E E E AT S C L VE AVGS T ADVP R R R VR QKGR F AMHAVNAAKL HF C G T7Promoter_Reverse
VP KP T E ANR L AVS KWL VQYC KE R HVVDS HI R T I VNT AL P R VF T P DAE DI QVVL DL HS VR AHDHR NAL AE AConsensus #1
150 160 170 180 190 200 210
VP KP T E ANR L AVS KWL VQYC KE R HVVDS HI R T I VNT AL P R VF T P DAE DI QVVL DL HS VR AHDHR NAL AE A TCVbGenome.txt
VP KP T E ANR L AVS KWL VQYC KE R HVVDS HI R T I VNT AL P R VF T P DAE DI QVVL DL HS VR AHDHR NAL AE A SP6_Forward
VP KP T E ANR L AVS KWL VQYC KE R HVVDS HI R T I VNT AL P R VF T P DAE DI QVVL DL HS VR AHDHR NAL AE A T7Promoter_Reverse
GKVR KWWVNL AMHP MT GR S WS R AWR R L C R L P DDQAI S F VR -Consensus #1
220 230 240 250
GKVR KWWVNL AMHP MT GR S WS R AWR R L C R L P DDQAI S F VR .                               TCVbGenome.txt
GKVR KWWVNL AMHP MT GR S C S R AC R R L C R L P DDQAI S F VR .                               SP6_Forward
GKVR KWWVNL AMHP MT GR S WS R AWR R L C R L P DDQAI S F VR .                               T7Promoter_Reverse  
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p88MUT sequence 
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A CConsensus #1
70 80 90 100 110 120
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C  TCVbGenome.txt
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C  SP6_FORWARD
T A C C C T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T AConsensus #1
130 140 150 160 170 180
T A C C C T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A  TCVbGenome.txt
T A C C C T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A  SP6_FORWARD
G T A C G G T C T G T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T CConsensus #1
190 200 210 220 230 240
G T A C G G T C T G T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C  TCVbGenome.txt
G T A C G G T C T G T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C  SP6_FORWARD
A G G G G G A C G T A T A G T A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T TConsensus #1
250 260 270 280 290 300
A G G G G G A C G T A T A G T A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T  TCVbGenome.txt
A G G G G G A C G T A T A G T A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T  SP6_FORWARD
C C G G A T A G C G G G G C G G A T A T A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A AConsensus #1
310 320 330 340 350 360
C C G G A T A G C G G G G C G G A T A T A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A  TCVbGenome.txt
C C G G A T A G C G G G G C G G A T A T A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A  SP6_FORWARD
G C C A C A T C C T G T T T G G T G G A G G C G G T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T TConsensus #1
370 380 390 400 410 420
G C C A C A T C C T G T T T G G T G G A G G C G G T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T  TCVbGenome.txt
G C C A C A T C C T G T T T G G T G G A G G C G G T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T  SP6_FORWARD
C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C G T C A A C G C A G C A A A G C T G C A C T T T T G T G G CConsensus #1
430 440 450 460 470 480
C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C  TCVbGenome.txt
C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C  SP6_FORWARD
G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T C T C A A A A T G G C T T G T C C A A T A C T G CConsensus #1
490 500 510 520 530 540
G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T C T C A A A A T G G C T T G T C C A A T A C T G C  TCVbGenome.txt
G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T C T C A A A A T G G C T T G T C C A A T A C T G C  SP6_FORWARD
A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G T C A A T A C G G C T C T T C C T A G AConsensus #1
550 560 570 580 590 600
A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G T C A A T A C G G C T C T T C C T A G A  TCVbGenome.txt
A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G T C A A T A C G G C T C T T C C T A G A  SP6_FORWARD
G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G C A C A G T G T A A G A G C AConsensus #1
610 620 630 640 650 660
G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G C A C A G T G T A A G A G C A  TCVbGenome.txt
G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G C A C A G T G T A A G A G C A  SP6_FORWARD
C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T G G G T C A A T C T CConsensus #1
670 680 690 700 710 720
C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T G G G T C A A T C T C  TCVbGenome.txt
C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T G G G T C A A T C T C  SP6_FORWARD
G C G A T G C A T C C C A T G A C T G G . A G G T C G T G G T C C A G G G C T T G .Consensus #1
730 740 750 760
G C G A T G C A T C C C A T G A C T G G G A G G T C G T G G T C C A G G G C T T G G                    TCVbGenome.txt
G C G A T G C A T C C C A T G A C T G G - A G G T C G T G G T C C A G G G C T T G A                   SP6_FORWARD  
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GGGCGAT T AT GCCGACT GCCT GACGACCAGGCGAT CT CT T T T GT CCGCT AGGGGT GCT T GCGGGAGCT GGT CGGGAGGGAConsensus #1
GGGCGAT T AT GCCGACT GCCT GACGACCAGGCGAT CT CT T T T GT CCGCT AGGGGT GCT T GCGGGAGCT GGT CGGGAGGGAMajority
770 780 790 800 810 820 830 840
AGGCGAT T AT GCCGACT GCCT GACGACCAGGCGAT CT CT T T T GT CCGCT AGGGGT GCT T GCGGGAGCT GGT CGGGAGGGA TCVbGenome.txt
GAGCGAT T AT GCCGACT GCCT GACGACCAGGCGAT CT CT T T T GT CCGCT AGGGGT GCT T GCGGGAGCT GGT CGGGAGGGA Nru_Forward
GACT CAAAT CT CCAGGGGT GAAAACCCGGCCAT GCGCGT GT T CCCGT T AGCAAAT CCCCCGAAGGT T CGACGCAT CT T CCConsensus #1
GACT CAAAT CT CCAGGGGT GAAAACCCGGCCAT GCGCGT GT T CCCGT T AGCAAAT CCCCCGAAGGT T CGACGCAT CT T CCMajority
850 860 870 880 890 900 910 920
GACT CAAAT CT CCAGGGGT GAAAACCCGGCCAT GCGCGT GT T CCCGT T AGCAAAT CCCCCGAAGGT T CGACGCAT CT T CC TCVbGenome.txt
GACT CAAAT CT CCAGGGGT GAAAACCCGGCCAT GCGCGT GT T CCCGT T AGCAAAT CCCCCGAAGGT T CGACGCAT CT T CC Nru_Forward
AT AT CT GT GGAAT GGGCAAT GGT T T AGACT T T GGAGT CCACAACAACT CACT CAACAAT T T GAGAAGAGGGT T GAT GGAAConsensus #1
AT AT CT GT GGAAT GGGCAAT GGT T T AGACT T T GGAGT CCACAACAACT CACT CAACAAT T T GAGAAGAGGGT T GAT GGAAMajority
930 940 950 960 970 980 990 1000
AT AT CT GT GGAAT GGGCAAT GGT T T AGACT T T GGAGT CCACAACAACT CACT CAACAAT T T GAGAAGAGGGT T GAT GGAA TCVbGenome.txt
AT AT CT GT GGAAT GGGCAAT GGT T T AGACT T T GGAGT CCACAACAACT CACT CAACAAT T T GAGAAGAGGGT T GAT GGAA Nru_Forward
AGAGT CT T T T ACGT T GAAGAT GCGCAGAAGCAAT T GAAACCAGCCCCCCAACCGAT CCCAGGGAT T T T CGGGAAGT T GAGConsensus #1
AGAGT CT T T T ACGT T GAAGAT GCGCAGAAGCAAT T GAAACCAGCCCCCCAACCGAT CCCAGGGAT T T T CGGGAAGT T GAGMajority
1010 1020 1030 1040 1050 1060 1070 1080
AGAGT CT T T T ACGT T GAAGAT GCGCAGAAGCAAT T GAAACCAGCCCCCCAACCGAT CCCAGGGAT T T T CGGGAAGT T GAG TCVbGenome.txt
AGAGT CT T T T ACGT T GAAGAT GCGCAGAAGCAAT T GAAACCAGCCCCCCAACCGAT CCCAGGGAT T T T CGGGAAGT T GAG Nru_Forward
T GGGAT T CGGAGACGAT T GGT CAGGT T GGCCGGAAAT CAT ACCCCT GT GCCT CGGGAGAAAT ACCCGT CGT T CT ACAAGGConsensus #1
T GGGAT T CGGAGACGAT T GGT CAGGT T GGCCGGAAAT CAT ACCCCT GT GCCT CGGGAGAAAT ACCCGT CGT T CT ACAAGGMajority
1090 1100 1110 1120 1130 1140 1150 1160
T GGGAT T CGGAGACGAT T GGT CAGGT T GGCCGGAAAT CAT ACCCCT GT GCCT CGGGAGAAAT ACCCGT CGT T CT ACAAGG TCVbGenome.txt
T GGGAT T CGGAGACGAT T GGT CAGGT T GGCCGGAAAT CAT ACCCCT GT GCCT CGGGAGAAAT ACCCGT CGT T CT ACAAGG Nru_Forward
GCAGGAGGGCCACCAT AT ACCAAAAGGCT T T GGAT T CT CT ACAT GACAGCCCGGT AT CCCGGAAGGACGCAGAACT CAAAConsensus #1
GCAGGAGGGCCACCAT AT ACCAAAAGGCT T T GGAT T CT CT ACAT GACAGCCCGGT AT CCCGGAAGGACGCAGAACT CAAAMajority
1170 1180 1190 1200 1210 1220 1230 1240
GCAGGAGGGCCACCAT AT ACCAAAAGGCT T T GGAT T CT CT ACAT GACAGCACGGT AT CCCGGAAGGACGCAGAACT CAAA TCVbGenome.txt
GCAGGAGGGCCACCAT AT ACCAAAAGGCT T T GGAT T CT CT ACAT GACAGACCGGT AT CCCGGAAGGACGCAGAACT CAAA Nru_Forward
ACAT T CGT GAAGGCAGAAAAGAT CAAT T T CACGGCT AAGAAAGACCCGGCT CCACGGGT CAT CCAGCCGAGGGACCCACGConsensus #1
ACAT T CGT GAAGGCAGAAAAGAT CAAT T T CACGGCT AAGAAAGACCCGGCT CCACGGGT CAT CCAGCCGAGGGACCCACGMajority
1250 1260 1270 1280 1290 1300 1310 1320
ACAT T CGT GAAGGCAGAAAAGAT CAAT T T CACGGCT AAGAAAGACCCGGCT CCACGGGT CAT CCAGCCGAGGGACCCACG TCVbGenome.txt
ACAT T CGT GAAGGCAGAAAAGAT CAAT T T CACGGCT AAGAAAGACCCGGCT CCACGGGT CAT CCAGCCGAGGGACCCACG Nru_Forward
AT AT AAT AT T GAGGT T GGGAAAT ACT T GAAACCGT ACGAGCACCAT T T AT AT CGGGCAAT T GACGCT AT GT GGGGT GGGCConsensus #1
AT AT AAT AT T GAGGT T GGGAAAT ACT T GAAACCGT ACGAGCACCAT T T AT AT CGGGCAAT T GACGCT AT GT GGGGT GGGCMajority
1330 1340 1350 1360 1370 1380 1390 1400
AT AT AACAT T GAGGT T GGGAAAT ACT T GAAACCGT ACGAGCACCAT T T AT AT CGGGCAAT T GACGCT AT GT GGGGT GGGC TCVbGenome.txt
AT AT AAT AT T GAGGT T GGGAAAT ACT T GAAACCGT ACGAGCACCAT T T AT AT CGGGCAAT T GACGCT AT GT GGGGT GGGC Nru_Forward
CCACT GT GCT GAAAGGAT ACGAT GT GGGGGAGCT T GGAAACAT T AT GAGT AACACCT GGGAT AAAT T CCGGAAAACGT GTConsensus #1
CCACT GT GCT GAAAGGAT ACGAT GT GGGGGAGCT T GGAAACAT T AT GAGT AACACCT GGGAT AAAT T CCGGAAAACGT GTMajority
1410 1420 1430 1440 1450 1460 1470 1480
CCACT GT GCT GAAAGGAT ACGAT GT GGGGGAGCT T GGAAACAT T AT GAGT AACACCT GGGAT AAAT T CCGGAAAACGT GT  TCVbGenome.txt
CCACT GT GCT GAAAGGAT ACGAT GT GGGGGAGCT T GGAAACAT T AT GAGT AACACCT GGGAT AAAT T CCGGAAAACGT GT  Nru_Forward
GCGAT AGGAT T T GACAT GAAGAGAT T CGACCAGCACGT AT CCGT GGACGCCCT ACGAT GGGAACACAGT GT AT ACAACGCConsensus #1
GCGAT AGGAT T T GACAT GAAGAGAT T CGACCAGCACGT AT CCGT GGACGCCCT ACGAT GGGAACACAGT GT AT ACAACGCMajority
1490 1500 1510 1520 1530 1540 1550 1560
GCGAT AGGAT T T GACAT GAAGAGAT T CGACCAGCACGT AT CCGT GGACGCCCT ACGAT GGGAACACAGT GT AT ACAACGC TCVbGenome.txt
GCGAT AGGAT T T GACAT GAAGAGAT T CGACCAGCACGT AT CCGT GGACGCCCT ACGAT GGGAACACAGT GT AT ACAACGC Nru_Forward
GConsensus #1
GMajority
G                                                                                TCVbGenome.txt
G                                                                                Nru_Forward
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GGCT T T AACT GT CCCGAGT T GGCACAGCT GCT AACT T GGCAGT T GACCAACAAGGGGGT T GGGAGAGCCTConsensus #1
1570 1580 1590 1600 1610 1620 1630
GGCT T T AACT GT CCCGAGT T GGCACAGCT GCT AACT T GGCAGT T GACCAACAAGGGGGT T GGGAGAGCCT  TCVbGenome.txt
GGCT T T AACT GT CCCGAGT T GGCACAGCT GCT AACT T GGCAGT T GACCAACAAGGGGGT T GGGAGAGCCT  T7Promoter_Reverse
CCGAT GGCT T T AT CAAAT ACCAAGT T GAT GGT T GT CGCAT GT CCGGAGAT GT T AACACAGCCT T GGGCAAConsensus #1
1640 1650 1660 1670 1680 1690 1700
CCGAT GGCT T T AT CAAAT ACCAAGT T GAT GGT T GT CGCAT GT CCGGAGAT GT T AACACAGCCT T GGGCAA TCVbGenome.txt
CCGAT GGCT T T AT CAAAT ACCAAGT T GAT GGT T GT CGCAT GT CCGGAGAT GT T AACACAGCCT T GGGCAA T7Promoter_Reverse
CT GCCT ACT GGCT T GCT CT AT CACCAAGT ACT T AAT GAAGGGAAT CAAAT GCAAAT T AAT CAACAAT GGAConsensus #1
1710 1720 1730 1740 1750 1760 1770
CT GCCT ACT GGCT T GCT CT AT CACCAAGT ACT T AAT GAAGGGAAT CAAAT GCAAAT T AAT CAACAAT GGA TCVbGenome.txt
CT GCCT ACT GGCT T GCT CT AT CACCAAGT ACT T AAT GAAGGGAAT CAAAT GCAAAT T AAT CAACAAT GGA T7Promoter_Reverse
GACGAT T GT GT GCT GT T CT T CGAAGCT GAT GAAGT CGACAGGGT GCGCGAAAGGCT GCAT CAT T GGAT CGConsensus #1
1780 1790 1800 1810 1820 1830 1840
GACGAT T GT GT GCT GT T CT T CGAAGCT GAT GAAGT CGACAGGGT GCGCGAAAGGCT GCAT CAT T GGAT CG TCVbGenome.txt
GACGAT T GT GT GCT GT T CT T CGAAGCT GAT GAAGT CGACAGGGT GCGCGAAAGGCT GCAT CAT T GGAT CG T7Promoter_Reverse
ACT T T GGGT T T CAAT GCAT AGCGGAAGAACCACAAT ACGAAT T GGAGAAAGT T GAAT T T T GCCAGAT GT CConsensus #1
1850 1860 1870 1880 1890 1900 1910
ACT T T GGGT T T CAAT GCAT AGCGGAAGAACCACAAT ACGAAT T GGAGAAAGT T GAAT T T T GCCAGAT GT C TCVbGenome.txt
ACT T T GGGT T T CAAT GCAT AGCGGAAGAACCACAAT ACGAAT T GGAGAAAGT T GAAT T T T GCCAGAT GT C T7Promoter_Reverse
CCCT AT T T T CGAT GGT GAAGGGT GGGT CAT GGT CAGAAACCCCCGT GT GAGCCT CT CCAAGGACAGCT ACConsensus #1
1920 1930 1940 1950 1960 1970 1980
CCCT AT T T T CGAT GGT GAAGGGT GGGT CAT GGT CAGAAACCCCCGT GT GAGCCT CT CCAAGGACAGCT AC TCVbGenome.txt
CCCT AT T T T CGAT GGT GAAGGGT GGGT CAT GGT CAGAAACCCCCGT GT GAGCCT CT CCAAGGACAGCT AC T7Promoter_Reverse
. GCACCACACAAT GGGCGAAT GAGAAAGAT GCAGCCAGAT GGT T GGCT GCCAT CGGAGAGT GT GGCT T GGConsensus #1
1990 2000 2010 2020 2030 2040 2050
AGCACCACACAAT GGGCGAAT GAGAAAGAT GCAGCCAGAT GGT T GGCT GCCAT CGGAGAGT GT GGCT T GG TCVbGenome.txt
T GCACCACACAAT GGGCGAAT GAGAAAGAT GCAGCCAGAT GGT T GGCT GCCAT CGGAGAGT GT GGCT T GG T7Promoter_Reverse
CT AT T GCAGGT GGCGT ACCAGT GT T ACAAT CAT AT T AT T CT T GCCT GAAGAGGAAT T T T GGACCCCT GGCConsensus #1
2060 2070 2080 2090 2100 2110 2120
CT AT T GCAGGT GGCGT ACCAGT GT T ACAAT CAT AT T AT T CT T GCCT GAAGAGGAAT T T T GGACCCCT GGC TCVbGenome.txt
CT AT T GCAGGT GGCGT ACCAGT GT T ACAAT CAT AT T AT T CT T GCCT GAAGAGGAAT T T T GGACCCCT GGC T7Promoter_Reverse
CGGGGACT ACAAGAAGAAGAT GCAAGAT GT T T CCT T T GAT AGT GGAT T CT ACAGGT T AT CCAAGAACGGGConsensus #1
2130 2140 2150 2160 2170 2180 2190
CGGGGACT ACAAGAAGAAGAT GCAAGAT GT T T CCT T T GAT AGT GGAT T CT ACAGGT T AT CCAAGAACGGG TCVbGenome.txt
CGGGGACT ACAAGAAGAAGAT GCAAGAT GT T T CCT T T GAT AGT GGAT T CT ACAGGT T AT CCAAGAACGGG T7Promoter_Reverse
AT GAGGGGCAGCAAAGACGT GT CCCAAGAT GCT AGGT T CAGCT T T T ACCGGGGGT T CGGCT ACACT CCAGConsensus #1
2200 2210 2220 2230 2240 2250 2260
AT GAGGGGCAGCAAAGACGT GT CCCAAGAT GCT AGGT T CAGCT T T T ACCGGGGGT T CGGCT ACACT CCAG TCVbGenome.txt
AT GAGGGGCAGCAAAGACGT GT CCCAAGAT GCT AGGT T CAGCT T T T ACCGGGGGT T CGGCT ACACT CCAG T7Promoter_Reverse
ACGAGCAGGAAGCGCT T GAGGAGT ACT ACGACAACCT . . AACT GCT CT GT GAGT GGGACCCCACGGGAT AConsensus #1
2270 2280 2290 2300 2310 2320 2330
ACGAGCAGGAAGCGCT T GAGGAGT ACT ACGACAACCT GCAACT GCT CT GT GAGT GGGACCCCACGGGAT A TCVbGenome.txt
ACGAGCAGGAAGCGCT T GAGGAGT ACT ACGACAACCT CGAACT GCT CT GT GAGT GGGACCCCACGGGAT A T7Promoter_Reverse
T AAAGAAGAACT T AGT GAT AGAT GGAT CCT GAACGAAT T CCCT ACAACT CT CT AAConsensus #1
2340 2350 2360 2370 2380 2390
T AAAGAAGAACT T AGT GAT AGAT GGAT CCT GAACGAAT T CCCT ACAACT CT CT AA                TCVbGenome.txt
T AAAGAAGAACT T AGT GAT AGAT GGAT CCT GAACGAAT T CCCT ACAACT CT CT AA                T7Promoter_Reverse
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p88MUT Translated 
MP L L H T L N T AL A V G L L G AR Y Y P E V QT F L G L P DY V G H MK NV V R S V F QG S G L V V VS S D T V G VConsensus #1
10 20 30 40 50 60
MP L L H T L N T AL A V G L L G AR Y Y P E V QT F L G L P DY V G H MK NV V R S V F QG S G L V V VS S D T V G V TCVbGenome.txt
MP L L H T L N T AL A V G L L G AR Y Y P E V QT F L G L P DY V G H MK NV V R S V F QG S G L V V VS S D T V G V SP6_FORWARD
R G T Y S N R G Q I G S S L G C I L A V P D S G AD I E I D L DR L V G T E E E A T S C L VE A V G S T AD V P R R R VConsensus #1
70 80 90 100 110 120
R G T Y S N R G Q I G S S L G C I L A V P D S G AD I E I D L DR L V G T E E E A T S C L VE A V G S T AD V P R R R V TCVbGenome.txt
R G T Y S N R G Q I G S S L G C I L A V P D S G AD I E I D L DR L V G T E E E A T S C L VE A V G S T AD V P R R R V SP6_FORWARD
R Q KG R F A MH AV N A A K L H F C G V P K P T E A N R L A VS K WL V Q YC K E R H V VD S H I R T I V N T A L P RConsensus #1
130 140 150 160 170 180
R Q KG R F A MH AV N A A K L H F C G V P K P T E A N R L A VS K WL V Q YC K E R H V VD S H I R T I V N T A L P R  TCVbGenome.txt
R Q KG R F A MH AV N A A K L H F C G V P K P T E A N R L A VS K WL V Q YC K E R H V VD S H I R T I V N T A L P R  SP6_FORWARD
V F T P D A E D I QV V L D L H S VR A H D H R NA L A E A G KV R K WWV NL A MH P MT G R S WS R AWConsensus #1
190 200 210 220 230
V F T P D A E D I QV V L D L H S VR A H D H R NA L A E A G KV R K WWV NL A MH P MT G R S WS R AW       TCVbGenome.txt
V F T P D A E D I QV V L D L H S VR A H D H R NA L A E A G KV R K WWV NL A MH P MT G R S WS R A        SP6_FORWARD
 
E R L C R L P D D Q A I S F V R - G C L R E L V G R E T Q I S R G E N P A M R V F P L A N P P K V RConsensus #1
770 780 790 800 810 820 830 840 850 860 870 880 890 900 910
R R L C R L P D D Q A I S F V R . G C L R E L V G R E T Q I S R G E N P A M R V F P L A N P P K V R  TCVbGenome.txt
E R L C R L P D D Q A I S F V R . G C L R E L V G R E T Q I S R G E N P A M R V F P L A N P P K V R  Nru_Forward
R I F H I C G M G N G L D F G V H N N S L N N L R R G L M E R V F Y V E D A Q K Q L K P A P Q P I PConsensus #1
920 930 940 950 960 970 980 990 1000 1010 1020 1030 1040 1050 1060
R I F H I C G M G N G L D F G V H N N S L N N L R R G L M E R V F Y V E D A Q K Q L K P A P Q P I P  TCVbGenome.txt
R I F H I C G M G N G L D F G V H N N S L N N L R R G L M E R V F Y V E D A Q K Q L K P A P Q P I P  Nru_Forward
G I F G K L S G I R R R L V R L A G N H T P V P R E K Y P S F Y K G R R A T I Y Q K A L D S L H D SConsensus #1
1070 1080 1090 1100 1110 1120 1130 1140 1150 1160 1170 1180 1190 1200 1210
G I F G K L S G I R R R L V R L A G N H T P V P R E K Y P S F Y K G R R A T I Y Q K A L D S L H D S  TCVbGenome.txt
G I F G K L S G I R R R L V R L A G N H T P V P R E K Y P S F Y K G R R A T I Y Q K A L D S L H D R  Nru_Forward
T V S R K D A E L K T F V K A E K I N F T A K K D P A P R V I Q P R D P R Y N I E V G K Y L K P Y EConsensus #1
1220 1230 1240 1250 1260 1270 1280 1290 1300 1310 1320 1330 1340 1350 1360
T V S R K D A E L K T F V K A E K I N F T A K K D P A P R V I Q P R D P R Y N I E V G K Y L K P Y E  TCVbGenome.txt
P V S R K D A E L K T F V K A E K I N F T A K K D P A P R V I Q P R D P R Y N I E V G K Y L K P Y E  Nru_Forward
H H L Y R A I D A M W G G P T V L K G Y D V G E L G N I M S N T W D K F R K T C A I G F D M K R F DConsensus #1
1370 1380 1390 1400 1410 1420 1430 1440 1450 1460 1470 1480 1490 1500 1510
H H L Y R A I D A M W G G P T V L K G Y D V G E L G N I M S N T W D K F R K T C A I G F D M K R F D  TCVbGenome.txt
H H L Y R A I D A M W G G P T V L K G Y D V G E L G N I M S N T W D K F R K T C A I G F D M K R F D  Nru_Forward
Q H V S V D A L R W E H S V Y N AConsensus #1
1520 1530 1540 1550 1560
Q H V S V D A L R W E H S V Y N A                                   TCVbGenome.txt
Q H V S V D A L R W E H S V Y N A                                   Nru_Forward
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G F N C P E L A Q L L T W Q L T N K G V G R A S D G F I K Y Q V D G C R M S G D V N T A L G N C L LConsensus #1
1570 1580 1590 1600 1610 1620 1630 1640 1650 1660 1670 1680 1690 1700 1710
G F N C P E L A Q L L T W Q L T N K G V G R A S D G F I K Y Q V D G C R M S G D V N T A L G N C L LTCVbGenome.txt
G F N C P E L A Q L L T W Q L T N K G V G R A S D G F I K Y Q V D G C R M S G D V N T A L G N C L LT7Promoter_Reverse
A C S I T K Y L M K G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H W I D F G F Q C IConsensus #1
1720 1730 1740 1750 1760 1770 1780 1790 1800 1810 1820 1830 1840 1850 1860
A C S I T K Y L M K G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H W I D F G F Q C ITCVbGenome.txt
A C S I T K Y L M K G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H W I D F G F Q C IT7Promoter_Reverse
A E E P Q Y E L E K V E F C Q M S P I F D G E G W V M V R N P R V S L S K D S Y S T T Q W A N E K DConsensus #1
1870 1880 1890 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010
A E E P Q Y E L E K V E F C Q M S P I F D G E G W V M V R N P R V S L S K D S Y S T T Q W A N E K DTCVbGenome.txt
A E E P Q Y E L E K V E F C Q M S P I F D G E G W V M V R N P R V S L S K D S Y C T T Q W A N E K DT7Promoter_Reverse
A A R W L A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K K K M Q D V S F DConsensus #1
2020 2030 2040 2050 2060 2070 2080 2090 2100 2110 2120 2130 2140 2150 2160
A A R W L A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K K K M Q D V S F DTCVbGenome.txt
A A R W L A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K K K M Q D V S F DT7Promoter_Reverse
S G F Y R L S K N G M R G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E Y Y D N L E L L CConsensus #1
2170 2180 2190 2200 2210 2220 2230 2240 2250 2260 2270 2280 2290 2300 2310
S G F Y R L S K N G M R G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E Y Y D N L Q L L CTCVbGenome.txt
S G F Y R L S K N G M R G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E Y Y D N L E L L CT7Promoter_Reverse
E W D P T G Y K E E L S D R W I L N E F P T T L -Consensus #1
2320 2330 2340 2350 2360 2370 2380 2390
E W D P T G Y K E E L S D R W I L N E F P T T L .                          TCVbGenome.txt
E W D P T G Y K E E L S D R W I L N E F P T T L .                          T7Promoter_Reverse
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p8 Sequence 
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T A A G C G A C A G C G A C G C A A CConsensus #1
2360 2370 2380 2390 2400
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T A A G C G A C A G C G A C G C A A C  TCVbGenome.txt
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T A A G C G A C A G C G A C G C A A C  SP6_Forward
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A GConsensus #1
2410 2420 2430 2440 2450
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A G  TCVbGenome.txt
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A G  SP6_Forward
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C TConsensus #1
2460 2470 2480 2490 2500
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C T  TCVbGenome.txt
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C T  SP6_Forward
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T CConsensus #1
2510 2520 2530 2540 2550
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T C  TCVbGenome.txt
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T C  SP6_Forward
A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A C G T C C C C G T G GConsensus #1
2560 2570 2580 2590 2600
A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A C G T C C C C G T G G  TCVbGenome.txt
A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A C G T C C C C G T G G  SP6_Forward
G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C C T A C T T T G T C AConsensus #1
2610 2620 2630 2640 2650
G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C C T A C T T T G T C A  TCVbGenome.txt
G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C C T A C T T T G T C A  SP6_Forward
T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A C A C A C A C G A C TConsensus #1
2660 2670 2680 2690 2700
T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A C A C A C A C G A C T  TCVbGenome.txt
T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A C A C A C A C G A C T  SP6_Forward
C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G G A A A A T G AConsensus #1
2710 2720 2730 2740 2750
C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G G A A A A T G A     TCVbGenome.txt
C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G G A A A A T G A     SP6_Forward
 
 
p8 Translated 
 
M D P E R I P Y N S L S D S D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G SConsensus #1
2360 2370 2380 2390 2400 2410 2420 2430 2440 2450 2460 2470 2480 2490 2500
M D P E R I P Y N S L S D S D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G STCVbGenome.txt
M D P E R I P Y N S L S D S D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G SSP6_Forward
A S H G G T WV I V A D K V E V S I N F N F - S E M S V P D V P V G N I C F L Q L S L T G P P T L SConsensus #1
2510 2520 2530 2540 2550 2560 2570 2580 2590 2600 2610 2620 2630 2640 2650
A S H G G T WV I V A D K V E V S I N F N F . S E M S V P D V P V G N I C F L Q L S L T G P P T L STCVbGenome.txt
A S H G G T WV I V A D K V E V S I N F N F . S E M S V P D V P V G N I C F L Q L S L T G P P T L SSP6_Forward
S D S - N Q T D S H I L Q H T R L I E A A T H K H Q H WK WK M NConsensus #1
2660 2670 2680 2690 2700 2710 2720 2730 2740 2750
S D S . N Q T D S H I L Q H T R L I E A A T H K H Q H WK WK M N                  TCVbGenome.txt
S D S . N Q T D S H I L Q H T R L I E A A T H K H Q H WK WK M N                  SP6_Forward
 69
p9MUT Sequence 
 
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A AConsensus #1
2500 2510 2520 2530 2540
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A  TCVbGenome.txt
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A  SP6_Forward
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G AConsensus #1
2550 2560 2570 2580 2590
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A  TCVbGenome.txt
G T G G A A G T C T C A A T C A A C T C C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A  SP6_Forward
C G T C C C C G T G G G T A G T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T CConsensus #1
2600 2610 2620 2630 2640
C G T C C C C G T G G G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C  TCVbGenome.txt
C G T C C C C G T G G G T A G T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C  SP6_Forward
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A AConsensus #1
2650 2660 2670 2680 2690
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A  TCVbGenome.txt
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A  SP6_Forward
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T GConsensus #1
2700 2710 2720 2730 2740
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G  TCVbGenome.txt
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G  SP6_Forward
G A A A A T G AConsensus #1
2750
G A A A A T G A                                            TCVbGenome.txt
G A A A A T G A                                            SP6_Forward
 
 
p9MUT Translated 
M K V L L V T G V L G L L L L I K W K S Q S T S T S N Q K C Q C P T S P W V V Y A F Y N S L S L V LConsensus #1
2500 2510 2520 2530 2540 2550 2560 2570 2580 2590 2600 2610 2620 2630 2640
M K V L L V T G V L G L L L L I K W K S Q S T S T S N Q K C Q C P T S P W V I Y A F Y N S L S L V L  TCVbGenome.txt
M K V L L V T G V L G L L L L I K W K S Q S T P T S N Q K C Q C P T S P W V V Y A F Y N S L S L V L  SP6_Forward
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K -Consensus #1
2650 2660 2670 2680 2690 2700 2710 2720 2730 2740 2750
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K .                TCVbGenome.txt
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K .                SP6_Forward
 
 70
p38 Sequence 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - . . . . . . . . . . . . . . . . . . G G . . . . . A A G T G G C A G A A G A A G G G CConsensus #1
2750 2760 2770 2780 2790 2800 2810
A T G G A A A A T G A T C C T A G A G T C C G G A A G T T C G C A T C T G A T G G C G C C C A A T G G G C G A T A A A G T G G C A G A A G A A G G G C  TCVbGenome.txt
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - N A N A N G A T T T A T A N N C A T G G G C G A T A A G T G G C A G A A G A A G G G C  CP_Forward
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  CP_Reverse
T G G T C A A C C C T A A C C A G C A G A C A G A A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A AConsensus #1
2820 2830 2840 2850 2860 2870 2880 2890
T G G T C A A C C C T A A C C A G C A G A C A G A A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A A  TCVbGenome.txt
T G G T C A A C C C T A A C C A G C A G A C A G A A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A A  CP_Forward
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  CP_Reverse
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C G C G A G G T T T C C A C C C A G C C T C G G G T CConsensus #1
2900 2910 2920 2930 2940 2950 2960
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C G C G A G G T T T C C A C C C A G C C T C G G G T C  TCVbGenome.txt
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C G C G A G G T T T C C A C C C A G C C T C G G G T C  CP_Forward
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - C C A C C C A G C C T C G G G T C  CP_Reverse
T C T A C T G C C A G G G A C G G C A T A A C C A G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A AConsensus #1
2970 2980 2990 3000 3010 3020 3030 3040
T C T A C T G C C A G G G A C G G C A T A A C C A G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A A  TCVbGenome.txt
T C T A C T G C C A G G G A C G G C A T A A C C A G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A A  CP_Forward
T C T A C T G C C A G G G A C G G C A T A A C C A G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A A  CP_Reverse
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A C C A G C T C A T T A A G G A G G C G G C C C A GConsensus #1
3050 3060 3070 3080 3090 3100 3110
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A C C A G C T C A T T A A G G A G G C G G C C C A G  TCVbGenome.txt
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A C C A G C T C A T T A A G G A G G C G G C C C A G  CP_Forward
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A C C A G C T C A T T A A G G A G G C G G C C C A G  CP_Reverse
T A T G A A A A A T A C C G A T T C A C G T C A C T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T GConsensus #1
3120 3130 3140 3150 3160 3170 3180 3190
T A T G A A A A A T A C C G A T T C A C G T C A C T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T G  TCVbGenome.txt
T A T G A A A A A T A C C G A T T C A C G T C A C T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T G  CP_Forward
T A T G A A A A A T A C C G A T T C A C G T C A C T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T G  CP_Reverse
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C C C C G C C C A A C G A C C T C G C T T C C C T C T A C A A C A T A G A G G G T T G TConsensus #1
3200 3210 3220 3230 3240 3250 3260
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C T C C G C C C A A C G A C C T C G C T T C C C T C T A C A A C A T A G A G G G T T G T  TCVbGenome.txt
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C C C C G C C C A A C G A C C T C G C T T C C C T C T A C A A C A T A G A G G G T T G T  CP_Forward
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C C C C G C C C A A C G A C C T C G C T T C C C T C T A C A A C A T A G A G G G T T G T  CP_Reverse
G T A T C T A G C G T G C C C T G G A C A G G G T T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T G T G G C G G A T G G TConsensus #1
3270 3280 3290 3300 3310 3320 3330 3340
G T A T C T A G C G T G C C C T G G A C A G G G T T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T G T G G C G G A T G G T  TCVbGenome.txt
G T A T C T A G C G T G C C C T G G A C A G G G T T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T G T G G C G G A T G G T  CP_Forward
G T A T C T A G C G T G C C C T G G A C A G G G T T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T G T G G C G G A T G G T  CP_Reverse
A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C CConsensus #1
3350 3360 3370 3380 3390 3400 3410
A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C  TCVbGenome.txt
A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C  CP_Forward
A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C  CP_Reverse
C A A C T C G G T G A A G T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C G A C G C C C A G A T TConsensus #1
3420 3430 3440 3450 3460 3470 3480 3490
C A A C T C G G T G A A G T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C G A C G C C C A G A T T  TCVbGenome.txt
C A A C T C G G T G A A G T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C G A C G C C C A G A T T  CP_Forward
C A A C T C G G T G A A G T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C G A C G C C C A G A T T  CP_Reverse
G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T C T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A GConsensus #1
3500 3510 3520 3530 3540 3550 3560
G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T T T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G  TCVbGenome.txt
G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T C T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G  CP_Forward
G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T C T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G  CP_Reverse
C A C G A T T G T C A T T T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C G G T C T C G G G G C T AConsensus #1
3570 3580 3590 3600 3610 3620 3630 3640
C A C G A T T G T C A T T T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C G G T C T C G G G G C T A  TCVbGenome.txt
C A C G A T T G T C A T T T T C T C G G A A C C N                                                    CP_Forward
C A C G A T T G T C A T T T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C G G T C T C G G G G C T A  CP_Reverse
G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G A A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A GConsensus #1
3650 3660 3670 3680 3690 3700 3710
G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G A A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G  TCVbGenome.txt
                                                                            CP_Forward
G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G A A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G  CP_Reverse
G T A G C A G A A A G G G G A C A A G G C G . . A A A . . . G T C A C A . . . G A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Consensus #1
3720 3730 3740 3750 3760 3770 3780 3790
G T A G C A G A A A G G G G A C A A G G C G T G A A A A T G G T C A C A A C T G A G G A G C A G C C A A A G G G T A A A T G G C A A G C A C T C A G A  TCVbGenome.txt
                                                                            CP_Forward
G T A G C A G A A A G G G G A C A A G G C G N A A A A - - T G T C A C A N T N G A N N C N A                               CP_Reverse
. . . . . .Consensus #1
A T T T A G                                                                       TCVbGenome.txt
                                                                           CP_Forward
                                                                           CP_Reverse
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p38 Translated 
X X X X X X X X X X X X X X X X X X X K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A Q P V Q K VConsensus #1
2750 2760 2770 2780 2790 2800 2810 2820 2830 2840 2850 2860 2870 2880 2890 2900
ME N D P R V R K F A S D G A Q WA I K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A Q P V Q K VTCVbGenome.txt
X X X X X X X X X X X K R F I N MG D K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A Q P V Q K VCP_Forward
X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X XCP_Reverse
T R L S A P V A L A Y R E V S T Q P R V S T A R D G I T R S G S E L I T T L K K N T D T E P K Y T T A V L N PConsensus #1
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S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K V A L A F D R D A A K P P P N DCP_Forward
S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K V A L A F D R D A A K P P P N DCP_Reverse
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L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R F V A D G I S D P K L V D F G K L I MA T Y G Q GTCVbGenome.txt
L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R F V A D G I S D P K L V D F G K L I MA T Y G Q GCP_Forward
L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R F V A D G I S D P K L V D F G K L I MA T Y G Q GCP_Reverse
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H D C H F L G T G N F S L T L F Y E K A P V S G L E N A D A S D F S V L G E A A A G S V Q WA G V K V A E R GTCVbGenome.txt
H D C H F L G T                                                CP_Forward
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Full-length TCV 
p28 ORF 
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C CConsensus #1
70 80 90 100 110 120
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C C  TCVbGenome.txt
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C C  TCVBtex_Forward
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C C  p28Rev_Reverse
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T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A G T A C G G T C T G  TCVbGenome.txt
T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A G T A C G G T C T G  TCVBtex_Forward
T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A G T A C G G T C T G  p28Rev_Reverse
T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G TConsensus #1
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T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G T  TCVbGenome.txt
T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G T  TCVBtex_Forward
T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G T  p28Rev_Reverse
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A TConsensus #1
260 270 280 290 300 310 320
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A T  TCVbGenome.txt
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A T  TCVBtex_Forward
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A T  p28Rev_Reverse
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G GConsensus #1
330 340 350 360 370 380
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G G  TCVbGenome.txt
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G G  TCVBtex_Forward
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G G  p28Rev_Reverse
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C CConsensus #1
390 400 410 420 430 440 450
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C  TCVbGenome.txt
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C  TCVBtex_Forward
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C  p28Rev_Reverse
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G TConsensus #1
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G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T  TCVbGenome.txt
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T  TCVBtex_Forward
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T  p28Rev_Reverse
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C T C A A A A T G G C T T G T C C A A T A C T G C A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G  TCVBtex_Forward
C T C A A A A T G G C T T G T C C A A T A C T G C A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G  p28Rev_Reverse
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T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G  TCVbGenome.txt
T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G  TCVBtex_Forward
T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G  p28Rev_Reverse
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Full-Length TCV 
Translated p28 ORF 
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Full-Length TCV 
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A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C CConsensus #1
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A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C C  TCVbGenome.txt
A T G C C T C T T C T A C A C A C A C T C A A C A C A G C G C T C G C A G T G G G A C T C C T A G G A G C C A G G T A C T A C C C  TCVBtex_Forward
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T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A G T A C G G T C T G  TCVbGenome.txt
T G A G G T T C A A A C C T T C T T G G G G C T G C C T G A C T A C G T G G G T C A C A T G A A G A A T G T A G T A C G G T C T G  TCVBtex_Forward
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T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G T  TCVbGenome.txt
T T T T C C A G G G A T C T G G G C T A G T A G T A G T G T C C T C C G A C A C A G T C G G T G T C A G G G G G A C G T A T A G T  TCVBtex_Forward
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A TConsensus #1
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A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A T  TCVbGenome.txt
A A T A G A G G T C A G A T A G G T A G T A G T C T C G G G T G T A T A C T A G C C G T T C C G G A T A G C G G G G C G G A T A T  TCVBtex_Forward
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G GConsensus #1
330 340 350 360 370 380
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G G  TCVbGenome.txt
A G A A A T A G A C C T A G A T A G G T T G G T A G G A A C G G A A G A G G A A G C C A C A T C C T G T T T G G T G G A G G C G G  TCVBtex_Forward
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C CConsensus #1
390 400 410 420 430 440 450
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C  TCVbGenome.txt
T A G G T A G T A C C G C A G A T G T C C C C A G G A G G A G A G T T C G T C A A A A G G G G C G G T T T G C T A T G C A T G C C  TCVBtex_Forward
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G TConsensus #1
460 470 480 490 500 510
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T  TCVbGenome.txt
G T C A A C G C A G C A A A G C T G C A C T T T T G T G G C G T C C C A A A A C C C A C T G A A G C G A A T C G A C T A G C G G T  TCVBtex_Forward
C T C A A A A T G G C T T G T C C A A T A C T G C A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A GConsensus #1
520 530 540 550 560 570 580
C T C A A A A T G G C T T G T C C A A T A C T G C A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G  TCVbGenome.txt
C T C A A A A T G G C T T G T C C A A T A C T G C A A A G A G A G A C A T G T C G T A G A C A G C C A C A T C A G A A C G A T A G  TCVBtex_Forward
T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T GConsensus #1
590 600 610 620 630 640
T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G  TCVbGenome.txt
T C A A T A C G G C T C T T C C T A G A G T G T T C A C G C C T G A C G C G G A A G A C A T T C A G G T C G T G C T G G A T T T G  TCVBtex_Forward
C A C A G T G T A A G A G C A C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T GConsensus #1
650 660 670 680 690 700 710
C A C A G T G T A A G A G C A C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T G  TCVbGenome.txt
C A C A G T G T A A G A G C A C A C G A C C A C C G C A A C G C C C T A G C C G A A G C A G G C A A A G T G C G G A A G T G G T G  TCVBtex_Forward
G G T C A A T C T C G C G A T G C A T C C C A T G A C T G G G A G G T C G T G G T C C A G G G C T T G G A G G C G A T T A T G C CConsensus #1
720 730 740 750 760 770
G G T C A A T C T C G C G A T G C A T C C C A T G A C T G G G A G G T C G T G G T C C A G G G C T T G G A G G C G A T T A T G C C  TCVbGenome.txt
G G T C A A T C T C G C G A T G C A T C C C A T G A C T G G G A G G T C G T G G T C C A G G G C T T G G A G G C G A T T A T G C C  TCVBtex_Forward
G A C T G C C T G A C G A C C A G G C G A T C T C T T T T G T C C G C T A G G G G T G C T T G C G G G A G C T G G T C G G G A G GConsensus #1
780 790 800 810 820 830 840
G A C T G C C T G A C G A C C A G G C G A T C T C T T T T G T C C G C T A G G G G T G C T T G C G G G A G C T G G T C G G G A G G  TCVbGenome.txt
G A C T G C C T G A C G A C C A G G C G A T C T C T T T T G T C C G C T A G G G G T G C T T G C G G G A G C T G G T C G G G A G G  TCVBtex_Forward
G A GConsensus #1
G A G                                                               TCVbGenome.txt
G A G                                                               TCVBtex_Forward
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T G G G A A C A C A G T G T A T A C A A C G C G G G C T T T A A C T G T C C C G A G T T G G C A C AConsensus #1
1550 1560 1570 1580 1590
T G G G A A C A C A G T G T A T A C A A C G C G G G C T T T A A C T G T C C C G A G T T G G C A C A  TCVbGenome.txt
T G G G A A C A C A G T G T A T A C A A C G C G G G C T T T A A C T G T C C C G A G T T G G C A C A  p88rev_Reverse
G C T G C T A A C T T G G C A G T T G A C C A A C A A G G G G G T T G G G A G A G C C T C C G A T GConsensus #1
1600 1610 1620 1630 1640
G C T G C T A A C T T G G C A G T T G A C C A A C A A G G G G G T T G G G A G A G C C T C C G A T G  TCVbGenome.txt
G C T G C T A A C T T G G C A G T T G A C C A A C A A G G G G G T T G G G A G A G C C T C C G A T G  p88rev_Reverse
G C T T T A T C A A A T A C C A A G T T G A T G G T T G T C G C A T G T C C G G A G A T G T T A A CConsensus #1
1650 1660 1670 1680 1690
G C T T T A T C A A A T A C C A A G T T G A T G G T T G T C G C A T G T C C G G A G A T G T T A A C  TCVbGenome.txt
G C T T T A T C A A A T A C C A A G T T G A T G G T T G T C G C A T G T C C G G A G A T G T T A A C  p88rev_Reverse
A C A G C C T T G G G C A A C T G C C T A C T G G C T T G C T C T A T C A C C A A G T A C T T A A TConsensus #1
1700 1710 1720 1730 1740
A C A G C C T T G G G C A A C T G C C T A C T G G C T T G C T C T A T C A C C A A G T A C T T A A T  TCVbGenome.txt
A C A G C C T T G G G C A A C T G C C T A C T G G C T T G C T C T A T C A C C A A G T A C T T A A T  p88rev_Reverse
G A A G G G A A T C A A A T G C A A A T T A A T C A A C A A T G G A G A C G A T T G T G T G C T G TConsensus #1
1750 1760 1770 1780 1790
G A A G G G A A T C A A A T G C A A A T T A A T C A A C A A T G G A G A C G A T T G T G T G C T G T  TCVbGenome.txt
G A A G G G A A T C A A A T G C A A A T T A A T C A A C A A T G G A G A C G A T T G T G T G C T G T  p88rev_Reverse
T C T T C G A A G C T G A T G A A G T C G A C A G G G T G C G C G A A A G G C T G C A T C A T T G GConsensus #1
1800 1810 1820 1830 1840
T C T T C G A A G C T G A T G A A G T C G A C A G G G T G C G C G A A A G G C T G C A T C A T T G G  TCVbGenome.txt
T C T T C G A A G C T G A T G A A G T C G A C A G G G T G C G C G A A A G G C T G C A T C A T T G G  p88rev_Reverse
A T C G A C T T T G G G T T T C A A T G C A T A G C G G A A G A A C C A C A A T A C G A A T T G G AConsensus #1
1850 1860 1870 1880 1890
A T C G A C T T T G G G T T T C A A T G C A T A G C G G A A G A A C C A C A A T A C G A A T T G G A  TCVbGenome.txt
A T C G A C T T T G G G T T T C A A T G C A T A G C G G A A G A A C C A C A A T A C G A A T T G G A  p88rev_Reverse
G A A A G T T G A A T T T T G C C A G A T G T C C C C T A T T T T C G A T G G T G A A G G G T G G GConsensus #1
1900 1910 1920 1930 1940
G A A A G T T G A A T T T T G C C A G A T G T C C C C T A T T T T C G A T G G T G A A G G G T G G G  TCVbGenome.txt
G A A A G T T G A A T T T T G C C A G A T G T C C C C T A T T T T C G A T G G T G A A G G G T G G G  p88rev_Reverse
T C A T G G T C A G A A A C C C C C G T G T G A G C C T C T C C A A G G A C A G C T A C A G C A C CConsensus #1
1950 1960 1970 1980 1990
T C A T G G T C A G A A A C C C C C G T G T G A G C C T C T C C A A G G A C A G C T A C A G C A C C  TCVbGenome.txt
T C A T G G T C A G A A A C C C C C G T G T G A G C C T C T C C A A G G A C A G C T A C A G C A C C  p88rev_Reverse
A C A C A A T G G G C G A A T G A G A A A G A T G C A G C C A G A T G G T T G G C T G C C A T C G GConsensus #1
2000 2010 2020 2030 2040
A C A C A A T G G G C G A A T G A G A A A G A T G C A G C C A G A T G G T T G G C T G C C A T C G G  TCVbGenome.txt
A C A C A A T G G G C G A A T G A G A A A G A T G C A G C C A G A T G G T T G G C T G C C A T C G G  p88rev_Reverse
A G A G T G T G G C T T G G C T A T T G C A G G T G G C G T A C C A G T G T T A C A A T C A T A T TConsensus #1
2050 2060 2070 2080 2090
A G A G T G T G G C T T G G C T A T T G C A G G T G G C G T A C C A G T G T T A C A A T C A T A T T  TCVbGenome.txt
A G A G T G T G G C T T G G C T A T T G C A G G T G G C G T A C C A G T G T T A C A A T C A T A T T  p88rev_Reverse
A T T C T T G C C T G A A G A G G A A T T T T G G A C C C C T G G C C G G G G A C T A C A A G A A GConsensus #1
2100 2110 2120 2130 2140
A T T C T T G C C T G A A G A G G A A T T T T G G A C C C C T G G C C G G G G A C T A C A A G A A G  TCVbGenome.txt
A T T C T T G C C T G A A G A G G A A T T T T G G A C C C C T G G C C G G G G A C T A C A A G A A G  p88rev_Reverse
A A G A T G C A A G A T G T T T C C T T T G A T A G T G G A T T C T A C A G G T T A T C C A A G A AConsensus #1
2150 2160 2170 2180 2190
A A G A T G C A A G A T G T T T C C T T T G A T A G T G G A T T C T A C A G G T T A T C C A A G A A  TCVbGenome.txt
A A G A T G C A A G A T G T T T C C T T T G A T A G T G G A T T C T A C A G G T T A T C C A A G A A  p88rev_Reverse
C G G G A T G A G G G G C A G C A A A G A C G T G T C C C A A G A T G C T A G G T T C A G C T T T TConsensus #1
2200 2210 2220 2230 2240
C G G G A T G A G G G G C A G C A A A G A C G T G T C C C A A G A T G C T A G G T T C A G C T T T T  TCVbGenome.txt
C G G G A T G A G G G G C A G C A A A G A C G T G T C C C A A G A T G C T A G G T T C A G C T T T T  p88rev_Reverse
A C C G G G G G T T C G G C T A C A C T C C A G A C G A G C A G G A A G C G C T T G A G G A G T A CConsensus #1
2250 2260 2270 2280 2290
A C C G G G G G T T C G G C T A C A C T C C A G A C G A G C A G G A A G C G C T T G A G G A G T A C  TCVbGenome.txt
A C C G G G G G T T C G G C T A C A C T C C A G A C G A G C A G G A A G C G C T T G A G G A G T A C  p88rev_Reverse
T A C G A C A A C C T G G A A C T G C T C T G T G A G T G G G A C C C CConsensus #1
2300 2310 2320
T A C G A C A A C C T G C A A C T G C T C T G T G A G T G G G A C C C C               TCVbGenome.txt
T A C G A C A A C C T C G A A C T G C T C T G T G A G T G G G A C C C C               p88rev_Reverse
 
  
 
 
 
 76
C T C T C AConsensus #1
2390
C T C T A A                                                            TCVbGenome.txt
A T C T C N                                                            TCV-BTEX-mid5-5
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TCV Construct 
Translated p88 ORF 
 
MP L L H T L N T A L A V G L L G A R Y Y P E V Q T F L G L P D Y V G H MK N V V R S V F Q G S G L V V V S S D T V G V R G T Y SConsensus #1
70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250
MP L L H T L N T A L A V G L L G A R Y Y P E V Q T F L G L P D Y V G H MK N V V R S V F Q G S G L V V V S S D T V G V R G T Y S  TCVbGenome.txt
MP L L H T L N T A L A V G L L G A R Y Y P E V Q T F L G L P D Y V G H MK N V V R S V F Q G S G L V V V S S D T V G V R G T Y S  TCVBtex_Forward
N R G Q I G S S L G C I L A V P D S G A D I E I D L D R L V G T E E E A T S C L V E A V G S T A D V P R R R V R Q K G R F A MH AConsensus #1
260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450
N R G Q I G S S L G C I L A V P D S G A D I E I D L D R L V G T E E E A T S C L V E A V G S T A D V P R R R V R Q K G R F A MH A  TCVbGenome.txt
N R G Q I G S S L G C I L A V P D S G A D I E I D L D R L V G T E E E A T S C L V E A V G S T A D V P R R R V R Q K G R F A MH A  TCVBtex_Forward
V N A A K L H F C G V P K P T E A N R L A V S K WL V Q Y C K E R H V V D S H I R T I V N T A L P R V F T P D A E D I Q V V L D LConsensus #1
460 470 480 490 500 510 520 530 540 550 560 570 580 590 600 610 620 630 640
V N A A K L H F C G V P K P T E A N R L A V S K WL V Q Y C K E R H V V D S H I R T I V N T A L P R V F T P D A E D I Q V V L D L  TCVbGenome.txt
V N A A K L H F C G V P K P T E A N R L A V S K WL V Q Y C K E R H V V D S H I R T I V N T A L P R V F T P D A E D I Q V V L D L  TCVBtex_Forward
H S V R A H D H R N A L A E A G K V R K WWV N L A MH P MT G R S WS R A WR R L C R L P D D Q A I S F V R - G C L R E L V G RConsensus #1
650 660 670 680 690 700 710 720 730 740 750 760 770 780 790 800 810 820 830 840
H S V R A H D H R N A L A E A G K V R K WWV N L A MH P MT G R S WS R A WR R L C R L P D D Q A I S F V R . G C L R E L V G R  TCVbGenome.txt
H S V R A H D H R N A L A E A G K V R K WWV N L A MH P MT G R S WS R A WR R L C R L P D D Q A I S F V R . G C L R E L V G R  TCVBtex_Forward
EConsensus #1
E                                                                  TCVbGenome.txt
E                                                                  TCVBtex_Forward  
WE H S V Y N A G F N C P E L A Q L L T WQ L T N K G V G R A S D G F I K Y Q V D G C R MS G D V NConsensus #1
1550 15601570 1580 15901600 1610 16201630 1640 16501660 1670 16801690
WE H S V Y N A G F N C P E L A Q L L T WQ L T N K G V G R A S D G F I K Y Q V D G C R MS G D V N  TCVbGenome.txt
WE H S V Y N A G F N C P E L A Q L L T WQ L T N K G V G R A S D G F I K Y Q V D G C R MS G D V N  p88rev_Reverse
T A L G N C L L A C S I T K Y L MK G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H WConsensus #1
1700 17101720 1730 17401750 1760 17701780 1790 18001810 1820 18301840
T A L G N C L L A C S I T K Y L MK G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H W TCVbGenome.txt
T A L G N C L L A C S I T K Y L MK G I K C K L I N N G D D C V L F F E A D E V D R V R E R L H H W p88rev_Reverse
I D F G F Q C I A E E P Q Y E L E K V E F C Q MS P I F D G E G WV MV R N P R V S L S K D S Y S TConsensus #1
1850 18601870 1880 18901900 1910 19201930 1940 19501960 1970 19801990
I D F G F Q C I A E E P Q Y E L E K V E F C Q MS P I F D G E G WV MV R N P R V S L S K D S Y S T  TCVbGenome.txt
I D F G F Q C I A E E P Q Y E L E K V E F C Q MS P I F D G E G WV MV R N P R V S L S K D S Y S T  p88rev_Reverse
T Q WA N E K D A A R WL A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K KConsensus #1
2000 20102020 2030 20402050 2060 20702080 2090 21002110 2120 21302140
T Q WA N E K D A A R WL A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K K  TCVbGenome.txt
T Q WA N E K D A A R WL A A I G E C G L A I A G G V P V L Q S Y Y S C L K R N F G P L A G D Y K K  p88rev_Reverse
K MQ D V S F D S G F Y R L S K N G MR G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E YConsensus #1
2150 21602170 2180 21902200 2210 22202230 2240 22502260 2270 22802290
K MQ D V S F D S G F Y R L S K N G MR G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E Y  TCVbGenome.txt
K MQ D V S F D S G F Y R L S K N G MR G S K D V S Q D A R F S F Y R G F G Y T P D E Q E A L E E Y  p88rev_Reverse
Y D N L E L L C E WD PConsensus #1
2300 23102320
Y D N L Q L L C E WD P                                        TCVbGenome.txt
Y D N L E L L C E WD P                                        p88rev_Reverse  
 
L S XConsensus #1
2390
L S N                                                 TCVbGenome.txt
Q S X                                                TCV-BTEX-mid5-5   
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TCV Construct 
P8 ORF 
 
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T C A G C G A C A G C G A C G C A A CConsensus #1
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T C A G C G A C A G C G A C G C A A CMajority
2360 2370 2380 2390 2400
A T G G A T C C T G A A C G A A T T C C C T A C A A C T C T C T A A G C G A C A G C G A C G C A A C  TCVbGenome.txt
- - - - - - - - - - - - - - - - - - - - - - - - - - - - A T C T C N G C G A N - G C G A C G C A A C  Mid5-Forward
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A GConsensus #1
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A GMajority
2410 2420 2430 2440 2450
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A G  TCVbGenome.txt
A G G A A A A C G G A A G A A A G G C G G A G A G A A A A G T G C G A A G A A G A G A T T G G T A G  Mid5-Forward
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C TConsensus #1
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C TMajority
2460 2470 2480 2490 2500
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C T  TCVbGenome.txt
C T A G C C A C G C G G C T A G C T C T G T T T T A A A C A A G A A A A G A A A T G A A G G T T C T  Mid5-Forward
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T CConsensus #1
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T CMajority
2510 2520 2530 2540 2550
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T C  TCVbGenome.txt
G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A G T G G A A G T C T C  Mid5-Forward
A A T C A A C T T C A A C T T C T A AConsensus #1
A A T C A A C T T C A A C T T C T A AMajority
2560 2570
A A T C A A C T T C A A C T T C T A A                                 TCVbGenome.txt
A A T C A A C T T C A A C T T C T A A                                Mid5-Forward   
 
TCV Construct 
Translated p8 ORF 
X X X X X X X X X X L S D X D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G SConsensus #1
X X X X X X X X X X L S D X D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G SMajority
23602370 2380 23902400 2410 24202430 2440 24502460 2470 24802490 2500
MD P E R I P Y N S L S D S D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G S  TCVbGenome.txt
X X X X X X X X X X L S E X D A T G K R K K G G E K S A K K R L V A S H A A S S V L N K K R N E G S  Mid5-Forward
A S H G G T WV I V A D K V E V S I N F N F -Consensus #1
A S H G G T WV I V A D K V E V S I N F N F -Majority
25102520 2530 25402550 2560 2570
A S H G G T WV I V A D K V E V S I N F N F .                             TCVbGenome.txt
A S H G G T WV I V A D K V E V S I N F N F                              Mid5-Forward
 
 
 
 
 
 
 
 
 
 
TCV Construct 
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P9 ORF 
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A AConsensus #1
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A AMajority
2500 2510 2520 2530 2540
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A  TCVbGenome.txt
A T G A A G G T T C T G C T A G T C A C G G G G G T A C T T G G G T T A T T G T T G C T G A T A A A  Mid5-Forward
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G AConsensus #1
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G AMajority
2550 2560 2570 2580 2590
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A  TCVbGenome.txt
G T G G A A G T C T C A A T C A A C T T C A A C T T C T A A T C A G A A A T G T C A G T G C C C G A  Mid5-Forward
C G T C C C C G T G G G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T CConsensus #1
C G T C C C C G T G G G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T CMajority
2600 2610 2620 2630 2640
C G T C C C C G T G G G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C  TCVbGenome.txt
C G T C C C C G T G G G T A A T A T A T G C T T T C T A C A A C T C T C T C T C A C T G G T C C T C  Mid5-Forward
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A AConsensus #1
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A AMajority
2650 2660 2670 2680 2690
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A  TCVbGenome.txt
C T A C T T T G T C A T C T G A T T C C T G A A A T C A A A C C G A T T C A C A C A T C C T A C A A  Mid5-Forward
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T GConsensus #1
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T GMajority
2700 2710 2720 2730 2740
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G  TCVbGenome.txt
C A C A C A C G A C T C A T C G A A G C A G C A A C A C A T A A G C A T C A A C A C T G G A A A T G  Mid5-Forward
G A A A A T G AConsensus #1
G A A A A T G AMajority
2750
G A A A A T G A                                            TCVbGenome.txt
G A A A A T G A                                           Mid5-Forward   
TCV 
Translated p9 ORF 
 
MK V L L V T G V L G L L L L I K WK S Q S T S T S N Q K C Q C P T S P WV I Y A F Y N S L S L V LConsensus #1
MK V L L V T G V L G L L L L I K WK S Q S T S T S N Q K C Q C P T S P WV I Y A F Y N S L S L V LMajority
2500 2510 25202530 2540 25502560 2570 25802590 2600 26102620 2630 2640
MK V L L V T G V L G L L L L I K WK S Q S T S T S N Q K C Q C P T S P WV I Y A F Y N S L S L V L  TCVbGenome.txt
MK V L L V T G V L G L L L L I K WK S Q S T S T S N Q K C Q C P T S P WV I Y A F Y N S L S L V L  Mid5-Forward
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K -Consensus #1
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K -Majority
2650 2660 26702680 2690 27002710 2720 27302740 2750
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K .                TCVbGenome.txt
L L C H L I P E I K P I H T S Y N T H D S S K Q Q H I S I N T G N G K .               Mid5-Forward   
 
 
 
 
 
 
 
TCV Construct 
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p38 ORF 
A T G G A A A A T G A T C C T A G A G T C C G G A A G T T C G C A T C T G A T G G C G C C C A A T GConsensus #1
A T G G A A A A T G A T C C T A G A G T C C G G A A G T T C G C A T C T G A T G G C G C C C A A T GMajority
2750 2760 2770 2780 2790
A T G G A A A A T G A T C C T A G A G T C C G G A A G T T C G C A T C T G A T G G C G C C C A A T G  TCVbGenome.txt
A T G G A A A A T G A T C C T A G A G T C C G G A A G T T C G C A T C T G A T G G C G C C C A A T G  HindIII_Reverse
G G C G A T A A A G T G G C A G A A G A A G G G C T G G T C A A C C C T A A C C A G C A G A C A G AConsensus #1
G G C G A T A A A G T G G C A G A A G A A G G G C T G G T C A A C C C T A A C C A G C A G A C A G AMajority
2800 2810 2820 2830 2840
G G C G A T A A A G T G G C A G A A G A A G G G C T G G T C A A C C C T A A C C A G C A G A C A G A  TCVbGenome.txt
G G C G A T A A A G T G G C A G A A G A A G G G C T G G T C A A C C C T A A C C A G C A G A C A G A  HindIII_Reverse
A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A AConsensus #1
A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A AMajority
2850 2860 2870 2880 2890
A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A A  TCVbGenome.txt
A A C A G A C C G C C C G C G C A G C G A T G G G G A T C A A G C T C T C T C C T G T G G C G C A A  HindIII_Reverse
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C GConsensus #1
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C GMajority
2900 2910 2920 2930 2940
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C G  TCVbGenome.txt
C C T G T G C A G A A A G T G A C T C G G C T G A G T G C T C C G G T G G C C C T T G C C T A C C G  HindIII_Reverse
C G A G G T T T C C A C C C A G C C T C G G G T C T C T A C T G C C A G G G A C G G C A T A A C C AConsensus #1
C G A G G T T T C C A C C C A G C C T C G G G T C T C T A C T G C C A G G G A C G G C A T A A C C AMajority
2950 2960 2970 2980 2990
C G A G G T T T C C A C C C A G C C T C G G G T C T C T A C T G C C A G G G A C G G C A T A A C C A  TCVbGenome.txt
C G A G G T T T C C A C C C A G C C T C G G G T C T C T A C T G C C A G G G A C G G C A T A A C C A  HindIII_Reverse
G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A AConsensus #1
G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A AMajority
3000 3010 3020 3030 3040
G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A A  TCVbGenome.txt
G A A G C G G T T C T G A A C T G A T C A C A A C C T T G A A G A A G A A C A C T G A C A C T G A A  HindIII_Reverse
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A AConsensus #1
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A AMajority
3050 3060 3070 3080 3090
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A  TCVbGenome.txt
C C T A A G T A C A C C A C A G C T G T G C T T A A C C C A A G C G A A C C C G G A A C A T T C A A  HindIII_Reverse
C C A G C T C A T T A A G G A G G C G G C C C A G T A T G A A A A A T A C C G A T T C A C G T C A CConsensus #1
C C A G C T C A T T A A G G A G G C G G C C C A G T A T G A A A A A T A C C G A T T C A C G T C A CMajority
3100 3110 3120 3130 3140
C C A G C T C A T T A A G G A G G C G G C C C A G T A T G A A A A A T A C C G A T T C A C G T C A C  TCVbGenome.txt
C C A G C T C A T T A A G G A G G C G G C C C A G T A T G A A A A A T A C C G A T T C A C G T C A C  HindIII_Reverse
T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T GConsensus #1
T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T GMajority
3150 3160 3170 3180 3190
T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T G  TCVbGenome.txt
T C A G A T T T A G G T A C T C C C C C A T G A G C C C T T C A A C C A C C G G A G G C A A G G T G  HindIII_Reverse
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C T C C G C C C A A C G A C C T C G CConsensus #1
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C T C C G C C C A A C G A C C T C G CMajority
3200 3210 3220 3230 3240
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C T C C G C C C A A C G A C C T C G C  TCVbGenome.txt
G C T C T G G C A T T C G A C C G A G A T G C A G C C A A A C C T C C G C C C A A C G A C C T C G C  HindIII_Reverse
T T C C C T C T A C A A C A T A G A G G G T T G T G T A T C T A G C G T G C C C T G G A C A G G G TConsensus #1
T T C C C T C T A C A A C A T A G A G G G T T G T G T A T C T A G C G T G C C C T G G A C A G G G TMajority
3250 3260 3270 3280 3290
T T C C C T C T A C A A C A T A G A G G G T T G T G T A T C T A G C G T G C C C T G G A C A G G G T  TCVbGenome.txt
T T C C C T C T A C A A C A T A G A G G G T T G T G T A T C T A G C G T G C C C T G G A C A G G G T  HindIII_Reverse
T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T TConsensus #1
T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T TMajority
3300 3310 3320 3330
T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T             TCVbGenome.txt
T T A T T T T G A C C G T C C C A A C A G A T T C T A C T G A C C G C T T T             HindIII_Reverse
 
  
 
 81
G T G G C G G A T G G T A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A TConsensus #1
G T G G C G G A T G G T A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A TMajority
3340 3350 3360 3370 3380
G T G G C G G A T G G T A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T  TCVbGenome.txt
G T G G C G G A T G G T A T C A G C G A T C C A A A G C T T G T C G A T T T C G G C A A G C T C A T  RC-TCV-BTEX-Btex3
C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C C A A C T C G G T G A A GConsensus #1
C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C C A A C T C G G T G A A GMajority
3390 3400 3410 3420 3430
C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C C A A C T C G G T G A A G  TCVbGenome.txt
C A T G G C C A C C T A C G G C C A A G G A G C C A A T G A T G C C G C C C A A C T C G G T G A A G  RC-TCV-BTEX-Btex3
T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G CConsensus #1
T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G CMajority
3440 3450 3460 3470 3480
T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C  TCVbGenome.txt
T G C G A G T C G A G T A C A C C G T G C A G C T C A A G A A C A G A A C T G G C T C A A C C A G C  RC-TCV-BTEX-Btex3
G A C G C C C A G A T T G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G TConsensus #1
G A C G C C C A G A T T G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G TMajority
3490 3500 3510 3520 3530
G A C G C C C A G A T T G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T  TCVbGenome.txt
G A C G C C C A G A T T G G G G A C T T C G C A G G T G T T A A G G A C G G A C C C A G G C T G G T  RC-TCV-BTEX-Btex3
T T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G C A C G A T T G T C A T TConsensus #1
T T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G C A C G A T T G T C A T TMajority
3540 3550 3560 3570 3580
T T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G C A C G A T T G T C A T T  TCVbGenome.txt
T T C A T G G T C C A A G A C C A A G G G G A C A G C T G G G T G G G A G C A C G A T T G T C A T T  RC-TCV-BTEX-Btex3
T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C GConsensus #1
T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C GMajority
3590 3600 3610 3620 3630
T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C G  TCVbGenome.txt
T T C T C G G A A C C G G A A A C T T C T C G T T G A C A T T G T T C T A C G A G A A G G C G C C G  RC-TCV-BTEX-Btex3
G T C T C G G G G C T A G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G AConsensus #1
G T C T C G G G G C T A G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G AMajority
3640 3650 3660 3670 3680
G T C T C G G G G C T A G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G A  TCVbGenome.txt
G T C T C G G G G C T A G A A A A C G C A G A C G C C T C T G A C T T C T C G G T C C T G G G A G A  RC-TCV-BTEX-Btex3
A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G G T A G C A G A A A G G GConsensus #1
A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G G T A G C A G A A A G G GMajority
3690 3700 3710 3720 3730
A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G G T A G C A G A A A G G G  TCVbGenome.txt
A G C C G C A G C A G G T A G T G T C C A A T G G G C A G G A G T G A A G G T A G C A G A A A G G G  RC-TCV-BTEX-Btex3
G A C A A G G C G T G A A A A T G G T C A C A A C T G A G G A G C A G C C A A A G G G T A A A T G GConsensus #1
G A C A A G G C G T G A A A A T G G T C A C A A C T G A G G A G C A G C C A A A G G G T A A A T G GMajority
3740 3750 3760 3770 3780
G A C A A G G C G T G A A A A T G G T C A C A A C T G A G G A G C A G C C A A A G G G T A A A T G G  TCVbGenome.txt
G A C A A G G C G T G A A A A T G G T C A C A A C T G A G G A G C A G C C A A A G G G T A A A T G G  RC-TCV-BTEX-Btex3
C A A G C A C T C A G A A T T T A GConsensus #1
C A A G C A C T C A G A A T T T A GMajority
3790
C A A G C A C T C A G A A T T T A G                                  TCVbGenome.txt
C A A G C A C T C A G A A T T T A G                                 RC-TCV-BTEX-Btex3  
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TCV Construct 
Translated p38 ORF  
 
ME N D P R V R K F A S D G A Q WA I K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A QConsensus #1
ME N D P R V R K F A S D G A Q WA I K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A QMajority
2750 2760 27702780 2790 28002810 2820 28302840 2850 28602870 2880 2890
ME N D P R V R K F A S D G A Q WA I K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A Q  TCVbGenome.txt
ME N D P R V R K F A S D G A Q WA I K WQ K K G WS T L T S R Q K Q T A R A A MG I K L S P V A Q  HindIII_Reverse
P V Q K V T R L S A P V A L A Y R E V S T Q P R V S T A R D G I T R S G S E L I T T L K K N T D T EConsensus #1
P V Q K V T R L S A P V A L A Y R E V S T Q P R V S T A R D G I T R S G S E L I T T L K K N T D T EMajority
2900 2910 29202930 2940 29502960 2970 29802990 3000 30103020 3030 3040
P V Q K V T R L S A P V A L A Y R E V S T Q P R V S T A R D G I T R S G S E L I T T L K K N T D T E  TCVbGenome.txt
P V Q K V T R L S A P V A L A Y R E V S T Q P R V S T A R D G I T R S G S E L I T T L K K N T D T E  HindIII_Reverse
P K Y T T A V L N P S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K VConsensus #1
P K Y T T A V L N P S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K VMajority
3050 3060 30703080 3090 31003110 3120 31303140 3150 31603170 3180 3190
P K Y T T A V L N P S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K V  TCVbGenome.txt
P K Y T T A V L N P S E P G T F N Q L I K E A A Q Y E K Y R F T S L R F R Y S P MS P S T T G G K V  HindIII_Reverse
A L A F D R D A A K P P P N D L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R FConsensus #1
A L A F D R D A A K P P P N D L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R FMajority
3200 3210 32203230 3240 32503260 3270 32803290 3300 33103320 3330
A L A F D R D A A K P P P N D L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R F      TCVbGenome.txt
A L A F D R D A A K P P P N D L A S L Y N I E G C V S S V P WT G F I L T V P T D S T D R F      HindIII_Reverse  
 
V A D G I S D P K L V D F G K L I MA T Y G Q G A N D A A Q L G E V R V E Y T V Q L K N R T G S T SConsensus #1
V A D G I S D P K L V D F G K L I MA T Y G Q G A N D A A Q L G E V R V E Y T V Q L K N R T G S T SMajority
33403350 3360 33703380 3390 34003410 3420 34303440 3450 34603470 3480
V A D G I S D P K L V D F G K L I MA T Y G Q G A N D A A Q L G E V R V E Y T V Q L K N R T G S T S  TCVbGenome.txt
V A D G I S D P K L V D F G K L I MA T Y G Q G A N D A A Q L G E V R V E Y T V Q L K N R T G S T S  RC-TCV-BTEX-Btex3
D A Q I G D F A G V K D G P R L V S WS K T K G T A G WE H D C H F L G T G N F S L T L F Y E K A PConsensus #1
D A Q I G D F A G V K D G P R L V S WS K T K G T A G WE H D C H F L G T G N F S L T L F Y E K A PMajority
34903500 3510 35203530 3540 35503560 3570 35803590 3600 36103620 3630
D A Q I G D F A G V K D G P R L V S WS K T K G T A G WE H D C H F L G T G N F S L T L F Y E K A P  TCVbGenome.txt
D A Q I G D F A G V K D G P R L V S WS K T K G T A G WE H D C H F L G T G N F S L T L F Y E K A P  RC-TCV-BTEX-Btex3
V S G L E N A D A S D F S V L G E A A A G S V Q WA G V K V A E R G Q G V K MV T T E E Q P K G K WConsensus #1
V S G L E N A D A S D F S V L G E A A A G S V Q WA G V K V A E R G Q G V K MV T T E E Q P K G K WMajority
36403650 3660 36703680 3690 37003710 3720 37303740 3750 37603770 3780
V S G L E N A D A S D F S V L G E A A A G S V Q WA G V K V A E R G Q G V K MV T T E E Q P K G K W TCVbGenome.txt
V S G L E N A D A S D F S V L G E A A A G S V Q WA G V K V A E R G Q G V K MV T T E E Q P K G K W RC-TCV-BTEX-Btex3
Q A L R I -Consensus #1
Q A L R I -Majority
3790
Q A L R I .                                              TCVbGenome.txt
Q A L R I .                                              RC-TCV-BTEX-Btex3  
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APPENDIX B 
 
HR TRACKING TABLES 
 
 
Table B-1:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with Agrobacterium carrying a vector 
expressing each of the TCV ORFs at an A600 = 0.3 in combination with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
Number indicates % of infiltrated site displaying HR lesions (tissue collapse). Three 
different plants were tested. Leaves 1 and 2 were taken from one plant, while leaf 3 
was taken from a second plant and leaves 4 and 5 were taken a third plant. 
 
  Day 4 Day 5 Day 6 Day 7 
Leaf 1         
p28MUT 5 10 12 20 
p88MUT 30 75 100 100 
p88MUT 5 20 45 75 
p9 2 15 20 25 
p38 20 50 90 90 
Leaf 2         
p28MUT 10 10 10 10 
p88MUT 5 10 10 10 
p88MUT 5 10 10 10 
p9 5 10 10 10 
p38 5 10 10 10 
Leaf 3         
p28MUT 15 90 100 100 
p88MUT 25 65 100 100 
p88MUT 100 100 100 100 
p9 100 100 100 100 
p38 100 100 100 100 
Leaf 4         
p28MUT 10 10 25 60 
p88MUT 65 100 100 100 
p88MUT 100 100 100 100 
p9 80 100 100 100 
p38 85 90 100 100 
Leaf 5         
p28MUT 100 100 100 100 
p88MUT 100 100 100 100 
p88MUT 100 100 100 100 
p9 100 100 100 100 
p38 100 100 100 100 
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Table B-2:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with Agrobacterium carrying a vector 
expressing each of the TCV ORFs at an A600 = 0.3 in combination with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
Number indicates % of infiltrated site displaying HR lesions (tissue collapse). Three 
different plants were tested. Leaves 1 and 2 were taken from one plant, while leaf 3 
was taken from a second plant and leaves 4 and 5 were taken a third plant. 
 
  Day 4 Day 5 Day 6 Day 7 
Leaf 1         
p28MUT,p88MUT 8 50 90 90 
p28MUT,p8 5 12 15 15 
p28MUT,p9 5 5 5 5 
p88MUT,p8 5 8 10 10 
p88MUT,p9 10 15 35 70 
p88MUT,p38 55 80 95 100 
p28MUT,p38 20 30 40 50 
p8,p9 65 75 85 95 
p8,p38 10 35 75 80 
p9,p38 10 15 20 35 
Leaf 2         
p28MUT,p88MUT 5 5 5 5 
p28MUT,p8 5 10 10 10 
p28MUT,p9 8 10 10 10 
p88MUT,p8 10 60 95 100 
p88MUT,p9 5 10 50 60 
p88MUT,p38 5 10 60 95 
p28MUT,p38 5 5 5 5 
p8,p9 5 8 10 10 
p8,p38 10 10 12 15 
p9,p38 2 2 2 2 
Leaf 3         
p28MUT,p88MUT 60 80 100 100 
p28MUT,p8 100 100 100 100 
p28MUT,p9 95 100 100 100 
p88MUT,p8 100 100 100 100 
p88MUT,p9 50 100 100 100 
p88MUT,p38 80 90 95 100 
p28MUT,p38 80 100 100 100 
p8,p9 90 100 100 100 
p8,p38 100 100 100 100 
p9,p38 80 100 100 100 
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 Table B-3:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with Agrobacterium carrying a vector 
expressing each of the TCV ORFs at an A600 = 0.3 in combination with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
Number indicates % of infiltrated site displaying HR lesions (tissue collapse). Three 
different plants were tested. Leaves 1 and 2 were taken from one plant, while leaf 3 
was taken from a second plant and leaves 4 and 5 were taken a third plant. 
 
  Day 4 Day 5 Day 6 Day 7 
Leaf 4         
p28MUT,p88MUT 100 100 100 100 
p28MUT,p8 100 100 100 100 
p28MUT,p9 80 100 100 100 
p88MUT,p8 100 100 100 100 
p88MUT,p9 100 100 100 100 
p88MUT,p38 80 100 100 100 
p28MUT,p38 100 100 100 100 
p8,p9 95 100 100 100 
p8,p38 100 100 100 100 
p9,p38 75 100 100 100 
Leaf 5         
p28MUT,p88MUT 100 100 100 100 
p28MUT,p8 95 100 100 100 
p28MUT,p9 60 80 90 100 
p88MUT,p8 100 100 100 100 
p88MUT,p9 95 100 100 100 
p88MUT,p38 100 100 100 100 
p28MUT,p38 100 100 100 100 
p8,p9 100 100 100 100 
p8,p38 100 100 100 100 
p9,p38 100 100 100 100 
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Table B-4:  Transient Expression Assay in N. benthamiana. Eight-week old N. 
Benthamiana plants were infiltrated with Agrobacterium carrying a vector 
expressing each of the TCV ORFs at an A600 = 0.3 in combination with 
Agrobacterium carrying vectors expressing AvrPto and Pto, each at an A600 = 0.3. 
Number indicates % of infiltrated site displaying HR lesions (tissue collapse). Three 
different plants were tested.  Both leaves were taken from the same plant. 
 
 Day 4 Day 5 Day 6 Day 7 
Leaf 1     
P8,p9,p38 5 8 10 10 
P8,p28MUT,p88MUT 5 15 30 70 
P9,p28MUT,p88MUT 5 10 25 35 
P28MUT,p38,p88MUT 2 2 2 2 
P8,p28MUT,p38 40 60 70 90 
P9,p28MUT,p38 5 10 15 50 
P8,p38,p88MUT 5 10 15 15 
P9,p38,p88MUT 8 15 15 80 
P8,p9,p38,p88MUT 10 10 15 25 
P8,p9,p28MUT,p38 2 2 5 15 
P8,p28MUT,p38,p88MUT 95 100 100 100 
P9,p28MUT,p38,p88MUT 10 12 15 30 
P8,p9,p28MUT,p88MUT 30 65 75 85 
Leaf 2     
P8,p9,p38 15 15 15 20 
P8,p28MUT,p88MUT 2 2 5 5 
P9,p28MUT,p88MUT 5 10 12 15 
P28MUT,p38,p88MUT 5 8 8 10 
P8,p28MUT,p38 5 6 10 10 
P9,p28MUT,p38 8 20 25 55 
P8,p38,p88MUT 15 20 20 30 
P9,p38,p88MUT 20 80 95 95 
P8,p9,p38,p88MUT 5 5 10 15 
P8,p9,p28MUT,p38 20 35 40 45 
P8,p28MUT,p38,p88MUT 15 50 65 75 
P9,p28MUT,p38,p88MUT 5 10 15 15 
P8,p9,p28MUT,p88MUT 15 35 40 50 
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